<?xml version="1.0" encoding="UTF-8"?>
<svg height="741.337" width="4314.724" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="95.358" x="56.693,64.856,70.158,72.706,75.862,78.409,81.354,86.656,92.066,96.446,99.602,102.15,107.246,112.655,117.036,119.584,122.683,127.887,131.562,136.658,141.862,146.325,150.0,153.155,157.536,159.692,162.709,165.865,171.167,175.547,179.957,182.949,187.329,191.71,197.10000000000002,200.184,205.388,207.936,211.611,216.115,220.495,223.651,226.199,230.609,233.633,236.789,241.169,244.844,249.538,253.919,257.055,260.165,264.57500000000005,267.536,270.691,273.239,277.012,280.785,286.087" svgx:width="0.83,0.54,0.26,0.32,0.26,0.29,0.54,0.55,0.45,0.32,0.26,0.52,0.55,0.45,0.26,0.55,0.53,0.38,0.52,0.53,0.45,0.38,0.32,0.45,0.22,0.55,0.32,0.54,0.45,0.45,0.55,0.45,0.45,0.55,0.55,0.53,0.26,0.38,0.45,0.45,0.32,0.26,0.45,0.55,0.32,0.45,0.38,0.48,0.45,0.32,0.55,0.45,0.55,0.32,0.26,0.38,0.38,0.54,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">multifunctional property, they can directly target a tissue</text>
   <text y="107.319" x="56.693,61.789,64.631,67.975,70.523,75.932,79.088,83.468,87.143,91.616,95.389,98.52499999999999,101.82,106.201,111.685,116.879,120.189,123.864,128.245,136.408,140.789,143.337,148.72699999999998,152.108,154.656,159.752,165.161,169.855,174.332,178.05599999999998,181.305,185.686,188.822,192.133,195.289,200.591,205.001,208.347,213.551,216.099,219.872,224.253,228.813,232.586,236.996,240.266,244.039,246.587,249.742,254.152,257.501,260.656,265.752,269.067,273.447,275.995,278.543,283.639" svgx:width="0.52,0.29,0.55,0.26,0.55,0.32,0.45,0.38,0.45,0.38,0.32,0.55,0.45,0.55,0.53,0.55,0.38,0.45,0.83,0.45,0.26,0.55,0.55,0.26,0.52,0.55,0.48,0.45,0.38,0.55,0.45,0.32,0.55,0.32,0.54,0.45,0.55,0.53,0.26,0.38,0.45,0.45,0.38,0.45,0.55,0.38,0.26,0.32,0.45,0.55,0.32,0.52,0.55,0.45,0.26,0.26,0.52,0.7" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">of interest and remain longer at the disease site to allow</text>
   <text y="119.338" x="56.693,59.848,65.15,69.56,73.077,76.233,81.329,84.484,88.865,91.413,95.017,98.173,101.848,106.228,111.638,115.411,118.263,122.74,126.464,129.94,135.036,137.87800000000001,141.392,144.548,149.85,154.26,157.834,163.037,166.712,172.014,176.71800000000002,180.227,188.391,193.487,196.035,200.58,204.96,210.262,212.81,217.191,220.964,223.12,226.715,233.859,236.407,239.259,242.111,246.491,250.166,254.547,259.957,263.093,266.741,274.904,280.0,282.548,286.929" svgx:width="0.32,0.54,0.45,0.55,0.32,0.52,0.32,0.45,0.26,0.55,0.32,0.38,0.45,0.55,0.38,0.29,0.45,0.38,0.55,0.52,0.29,0.55,0.32,0.54,0.45,0.55,0.53,0.38,0.54,0.48,0.55,0.83,0.52,0.26,0.45,0.45,0.54,0.26,0.45,0.38,0.22,0.55,0.73,0.26,0.29,0.29,0.45,0.38,0.45,0.55,0.32,0.55,0.83,0.52,0.26,0.45,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">the total transfer of the drug molecules. Different mole-</text>
   <text y="131.357" x="56.693,61.073,66.375,68.923,73.304,77.028,80.164,85.26,92.09,97.5,101.88,107.074,110.154,115.25,119.66,122.683,127.064,132.474,135.629,138.177,141.744,144.292,149.702,152.674,155.222,159.603,167.766,175.929,180.31,183.465,188.674,192.349,196.759,199.729,204.11,208.804,213.185,218.594,221.954,225.922,228.078,231.081,233.629,239.039,242.812,248.113,250.661,253.209,258.619,260.77500000000003,263.85,268.231,272.611,278.021,282.401,286.782" svgx:width="0.45,0.54,0.26,0.45,0.38,0.55,0.52,0.7,0.55,0.45,0.53,0.55,0.52,0.45,0.55,0.45,0.55,0.32,0.26,0.36,0.26,0.55,0.29,0.26,0.45,0.83,0.83,0.45,0.32,0.52,0.38,0.45,0.55,0.45,0.48,0.45,0.55,0.32,0.38,0.22,0.55,0.26,0.55,0.38,0.54,0.26,0.26,0.55,0.22,0.55,0.45,0.45,0.55,0.45,0.45,0.38" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">cules owned by anti-inflammatory agents, insulin, cancer</text>
   <text y="143.318" x="56.693,61.073,64.229,68.61,70.746,72.902,75.911,82.742,87.123,90.798,95.208,98.136,101.811,106.191,109.347,111.895,116.991,122.514,126.894,129.442,131.99,136.273,140.654,145.84799999999998,148.877,154.178,158.559,162.234,166.614,169.162,174.572" svgx:width="0.45,0.32,0.45,0.22,0.22,0.55,0.7,0.45,0.38,0.45,0.55,0.38,0.45,0.32,0.26,0.52,0.55,0.45,0.26,0.26,0.44,0.45,0.53,0.55,0.54,0.45,0.38,0.45,0.26,0.55,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">etc., were rationalized herein.</text>
   <text y="155.337" x="64.687,70.194,73.967,77.74,82.205,87.615,90.77,93.318,97.699,100.247,105.903,111.411,118.555,123.308,130.26600000000002,135.894,139.049,142.724,147.105,152.514,156.287,161.575,166.671,170.346,173.502,177.882,181.557,185.28099999999998,191.0,196.095,198.937,204.606,208.986,214.37599999999998,220.083,224.463,229.559,232.107,237.409,245.572,248.12,253.645,258.026,260.574,266.231,274.395,278.775,286.939" svgx:width="0.56,0.38,0.38,0.45,0.55,0.32,0.26,0.45,0.26,0.55,0.56,0.73,0.52,0.71,0.55,0.32,0.38,0.45,0.55,0.38,0.53,0.52,0.38,0.32,0.45,0.38,0.38,0.55,0.52,0.29,0.55,0.45,0.55,0.55,0.45,0.52,0.26,0.54,0.83,0.26,0.55,0.45,0.26,0.55,0.83,0.45,0.83,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">Essential PUFA transporters of an abluminal mem-</text>
   <text y="167.355" x="56.693,61.789,65.464,69.844,75.254,79.664,83.962,89.058,91.9,96.208,99.364,104.665,109.075,113.386,117.767,123.176,128.38,133.476,136.632,141.933,146.314,148.862,151.541,155.922,158.47,162.766,167.147,171.527,174.075,176.623,180.34699999999998,184.706,189.802,192.644,196.952,202.763,208.575,214.357,218.778,223.159,225.707,228.255,233.351,240.181,244.687,249.881,254.155,257.311,262.612,267.02200000000005,271.333,277.968,285.507" svgx:width="0.52,0.38,0.45,0.55,0.45,0.55,0.52,0.29,0.55,0.32,0.54,0.45,0.55,0.45,0.55,0.53,0.52,0.32,0.54,0.45,0.26,0.26,0.45,0.26,0.55,0.45,0.45,0.26,0.26,0.38,0.55,0.52,0.29,0.55,0.59,0.59,0.59,0.55,0.45,0.26,0.26,0.52,0.7,0.45,0.53,0.55,0.32,0.54,0.45,0.55,0.68,0.76,0.51" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">brane of the endothelial cells of BBB allowed the CNS</text>
   <text y="179.317" x="56.693,61.073,65.454,68.61,71.158,76.567,81.27099999999999,86.06,90.441,94.214,97.987,102.367,107.777,110.932,113.48,117.861,120.409,125.179,130.686,137.83,142.583,149.541,154.262,157.417,162.513,170.677,175.057,179.751,184.132,187.699,192.59900000000002,197.406,201.786,207.196,212.39,217.135,222.231,230.394,234.775,239.469,243.849,247.522,252.422,255.578,257.734,262.433,266.843,271.504,274.052,276.6,281.879,286.975" svgx:width="0.45,0.45,0.32,0.26,0.55,0.48,0.55,0.45,0.38,0.38,0.45,0.55,0.32,0.26,0.45,0.26,0.55,0.56,0.73,0.52,0.71,0.55,0.32,0.52,0.83,0.45,0.48,0.45,0.36,0.5,0.55,0.45,0.55,0.53,0.55,0.52,0.83,0.45,0.48,0.45,0.36,0.5,0.32,0.22,0.55,0.45,0.55,0.26,0.26,0.53,0.52,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">acting essential PUFA (omega-3 and omega-6), a lipo-</text>
   <text y="191.336" x="56.693,61.897,67.198,69.746,72.294,74.842,79.252,83.905,92.069,97.165,99.712,104.093,107.249,111.65899999999999,116.334,118.882,124.292,127.447,132.543,137.197,140.353,145.654,150.064,154.715,159.811,163.486,167.867,170.415,175.805,180.511" svgx:width="0.53,0.54,0.26,0.26,0.26,0.45,0.55,0.83,0.52,0.26,0.45,0.32,0.45,0.55,0.26,0.55,0.32,0.52,0.55,0.32,0.54,0.45,0.55,0.52,0.38,0.45,0.26,0.55,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">philic moiety into the brain [</text>
   <text y="191.336" x="183.628,188.528" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">80</text>
   <text y="191.336" x="193.493,196.648,198.804,203.414,210.862,215.958,221.367,223.915,229.011,234.421,236.969,241.379,246.048,249.821,255.122,258.797,261.649,266.117,270.497,273.653,278.033,283.443,286.753" svgx:width="0.32,0.22,0.55,0.76,0.52,0.55,0.26,0.52,0.55,0.26,0.45,0.55,0.38,0.54,0.38,0.29,0.45,0.45,0.32,0.45,0.55,0.32,0.38" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">]. Nonionic surfactants</text>
   <text y="203.354" x="56.693,59.848,63.004,69.835,74.215,78.596,83.986,87.024,91.924,96.82400000000001,99.779,104.16,109.569,114.763,117.751,122.955,128.051,130.599,135.78,140.572,144.953,153.116,157.497,161.172,164.308,167.301,171.682,176.984,181.758,189.922,194.302,199.712,202.867,207.248,212.44199999999998,215.434,220.53,224.278,228.659,231.207,236.59699999999998,239.585,242.741,247.122,250.797,255.491,259.871,263.027,265.575,270.984,275.688,278.704,283.084,286.981" svgx:width="0.32,0.32,0.7,0.45,0.45,0.55,0.55,0.5,0.5,0.55,0.45,0.55,0.53,0.55,0.53,0.52,0.26,0.52,0.49,0.45,0.83,0.45,0.38,0.32,0.55,0.45,0.54,0.48,0.83,0.45,0.55,0.32,0.45,0.53,0.55,0.52,0.38,0.45,0.26,0.55,0.55,0.32,0.45,0.38,0.48,0.45,0.32,0.26,0.55,0.48,0.55,0.45,0.38,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">(tween 80 and poloxamer) augmented brain targeting es-</text>
   <text y="215.316" x="56.693,60.466,64.846,70.256,73.412,75.96,80.34,82.888,86.287,91.794,98.938,103.634,110.592,113.896,117.051,122.353,126.028,131.124,136.426,141.12,146.412,149.783,152.331,154.879,160.083,165.26,170.464,174.139,179.235,182.39,186.771,189.319,194.709,198.086,201.761,206.249,210.63,215.01,220.214,223.37,228.466,232.044,235.612,243.775,248.156,253.359,255.907,260.288,263.443,267.824,273.01800000000003,276.435,281.737,286.941" svgx:width="0.38,0.45,0.55,0.32,0.26,0.45,0.26,0.55,0.56,0.73,0.52,0.71,0.55,0.32,0.54,0.38,0.52,0.54,0.48,0.54,0.55,0.26,0.26,0.53,0.52,0.53,0.38,0.52,0.32,0.45,0.26,0.55,0.55,0.38,0.45,0.45,0.45,0.53,0.32,0.52,0.38,0.36,0.83,0.45,0.53,0.26,0.45,0.32,0.45,0.53,0.55,0.54,0.53,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">sential PUFA through lipoprotein receptor-mediated up-</text>
   <text y="227.335" x="56.693,59.848,64.229,69.129,73.539,78.01,83.106,89.936,92.484,97.894,102.598,107.093,110.248,115.34400000000001,119.792,122.948,128.25,132.66,137.083,141.464,144.316,147.168,149.716,155.125,157.777,160.932,165.34199999999998,169.739,174.835,177.67700000000002,182.154,186.535,191.738,196.834,199.382,201.93,207.134,212.23,217.434,221.216,226.312,229.467,233.848,236.396,241.786,246.274,251.762,256.252,259.104,264.2,267.924,272.353,277.861,285.005" svgx:width="0.32,0.45,0.5,0.45,0.55,0.52,0.7,0.26,0.55,0.48,0.55,0.32,0.52,0.55,0.32,0.54,0.45,0.55,0.45,0.29,0.29,0.26,0.55,0.26,0.32,0.45,0.55,0.52,0.29,0.55,0.45,0.53,0.52,0.26,0.26,0.53,0.52,0.53,0.38,0.52,0.32,0.45,0.26,0.55,0.55,0.56,0.55,0.29,0.52,0.38,0.55,0.56,0.73,0.56" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">take owing to the affinity of apolipoprotein E for LDL</text>
   <text y="239.353" x="56.693,60.368,64.857,69.238,73.618,78.822,81.978,87.194,90.918,94.791,97.339,102.729,106.697,109.852,115.154,119.564,123.535,129.346,135.158,140.94,144.966,149.346,154.756,159.136,164.232,166.78,171.161,176.355,180.342,185.644,190.848,194.003,198.484,203.384,207.79399999999998,211.693,216.789,221.19899999999998,225.13,231.309,240.394,245.882,249.848,253.004,256.678,261.186,265.567,269.948,275.151,278.307,283.403,286.982" svgx:width="0.38,0.45,0.45,0.45,0.53,0.32,0.52,0.38,0.55,0.26,0.55,0.55,0.32,0.54,0.45,0.55,0.59,0.59,0.59,0.55,0.45,0.55,0.45,0.52,0.26,0.45,0.53,0.55,0.54,0.53,0.32,0.45,0.5,0.45,0.55,0.52,0.45,0.55,0.61,0.93,0.56,0.55,0.32,0.38,0.45,0.45,0.45,0.53,0.32,0.52,0.38,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">receptor in the BBB enabled uptake by RME (receptor-</text>
   <text y="251.315" x="56.693,64.856,69.237,74.441,76.988,81.468,84.624,89.004,94.19800000000001,100.007,104.387,109.797,115.0,120.096,124.477,128.857,132.013,137.109,140.882,143.43,147.346,150.501,152.657,158.401,161.665,167.055,172.858,177.239,182.648,187.825,190.981,196.283,200.663,204.387,210.162,212.71,218.12,221.893,225.048,229.429,234.838,239.219,243.6,245.756,251.605,255.986,261.395,266.697,271.077,276.487,280.868,285.248" svgx:width="0.83,0.45,0.53,0.26,0.45,0.32,0.45,0.53,0.55,0.45,0.55,0.53,0.52,0.45,0.45,0.32,0.52,0.38,0.26,0.38,0.32,0.22,0.55,0.33,0.55,0.55,0.45,0.55,0.52,0.32,0.54,0.45,0.38,0.55,0.26,0.55,0.38,0.32,0.45,0.55,0.45,0.45,0.22,0.55,0.45,0.55,0.54,0.45,0.55,0.45,0.45,0.53" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">mediated endocytosis). In another instance, enhanced</text>
   <text y="263.334" x="56.693,61.789,65.464,69.844,72.392,77.782,81.865,87.167,92.37,95.526,100.007,104.906,109.316,113.329,118.425,121.267,125.348,130.552,135.648,140.44,145.536,149.211,154.602,159.698,162.246,166.626,169.174,174.56400000000002,178.64,182.315,186.695,190.468,195.77,198.318,201.474,205.966,211.16,215.207,222.038,224.586,227.741,233.03300000000002,237.147,242.351,246.026,251.328,256.022,259.55,263.68,266.227,271.323,275.704,280.908,285.288" svgx:width="0.52,0.38,0.45,0.26,0.55,0.55,0.54,0.53,0.32,0.45,0.5,0.45,0.55,0.52,0.29,0.55,0.53,0.52,0.49,0.52,0.38,0.54,0.52,0.26,0.45,0.26,0.55,0.55,0.38,0.45,0.38,0.54,0.26,0.32,0.45,0.53,0.55,0.7,0.26,0.32,0.54,0.55,0.53,0.38,0.54,0.48,0.36,0.55,0.26,0.52,0.45,0.53,0.45,0.53" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">brain uptake of doxorubicin resulted with drug- loaded</text>
   <text y="275.352" x="56.693,65.777,71.285,75.009,81.865,88.695,91.243,94.399,99.691,106.526,111.73,115.405,117.953,123.363,127.743,130.291,135.495,139.975,142.523,149.273,151.821,157.23,160.386,164.766,168.441,172.914,177.294,180.45,182.998,188.094,193.48399999999998,200.297,205.393,208.235,215.037,224.121,229.609,236.467,240.848,246.257,249.413,251.961,255.116,257.664,262.045,265.769,272.638,279.468,282.016,285.172" svgx:width="0.93,0.56,0.38,0.55,0.7,0.26,0.32,0.54,0.55,0.53,0.38,0.26,0.55,0.45,0.26,0.53,0.45,0.26,0.55,0.26,0.55,0.32,0.45,0.38,0.45,0.45,0.32,0.26,0.52,0.55,0.55,0.52,0.29,0.55,0.93,0.56,0.55,0.45,0.55,0.32,0.26,0.32,0.26,0.45,0.38,0.55,0.7,0.26,0.32,0.54" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">MEs with principal interaction of ME entities with</text>
   <text y="287.314" x="56.693,61.897,64.445,68.939,72.712,80.875,85.285,88.498,92.879,98.083,103.179,105.727,108.275,113.478,118.574,123.778,127.56,132.656,135.811,140.192,142.74,148.13,151.428" svgx:width="0.53,0.26,0.45,0.38,0.83,0.45,0.55,0.45,0.53,0.52,0.26,0.26,0.53,0.52,0.53,0.38,0.52,0.32,0.45,0.26,0.55,0.55,0.71" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">plasma apolipoprotein A</text>
   <text y="287.314" x="158.399" svgx:width="0.6" style="fill:rgb(19,20,19);font-family:YnkvgbAdvTT86d47313;font-size:9.8px;stroke:none;">–</text>
   <text y="287.314" x="164.295,167.529,170.758,173.61,177.99,182.371,184.919,187.467,190.015,193.17,197.551,200.706,205.227,210.421,213.618,217.391,221.771,226.152,230.64,235.021,240.43,245.124,249.505,253.22899999999998,256.365,260.04,264.585,268.966,273.346,278.55,281.705,286.801" svgx:width="0.33,0.55,0.29,0.45,0.45,0.26,0.26,0.26,0.32,0.45,0.32,0.45,0.53,0.55,0.38,0.45,0.45,0.46,0.45,0.55,0.48,0.45,0.38,0.55,0.38,0.45,0.45,0.45,0.53,0.32,0.52,0.38" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">I facilitated scavenger receptor</text>
   <text y="299.333" x="56.692,59.24,64.63,67.634,73.445,79.256,85.038,88.043,92.423,97.833,103.037,108.133,111.288,116.59,120.97,123.646,126.194,131.496,139.63,142.638" svgx:width="0.26,0.55,0.55,0.59,0.59,0.59,0.55,0.45,0.55,0.53,0.52,0.32,0.54,0.45,0.26,0.26,0.54,0.83,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">in BBB endothelium [</text>
   <text y="299.333" x="145.813,150.713" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">81</text>
   <text y="299.333" x="155.621,158.776" svgx:width="0.32,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">].</text>
   <text y="311.351" x="64.686,71.32,76.622,80.297,84.755,90.057,98.22,100.768,106.158,110.607,114.988,120.397,124.778,129.158,134.362,138.135,143.545,146.093,150.474,153.63,158.01,163.20399999999998,167.641,172.736,177.146,181.53,185.94,190.317,194.698,199.794,208.062,213.158,215.706,221.116,225.496,228.652,231.2,236.296,241.68599999999998,246.16,251.256,254.098,258.519,262.899,267.363,270.519,273.067,278.163,283.572,286.12" svgx:width="0.68,0.54,0.38,0.45,0.54,0.83,0.26,0.55,0.55,0.45,0.55,0.45,0.45,0.53,0.38,0.54,0.26,0.45,0.32,0.45,0.53,0.55,0.52,0.45,0.55,0.45,0.55,0.45,0.52,0.83,0.52,0.26,0.55,0.45,0.32,0.26,0.52,0.55,0.55,0.52,0.29,0.55,0.45,0.45,0.32,0.26,0.52,0.55,0.26,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">Curcumin encapsulated by a combination of cationic</text>
   <text y="323.313" x="56.692,60.465,65.767,69.442,72.293,76.761,81.142,84.297,88.678,94.087,97.398,101.122,106.185,109.958,115.26,119.641,124.933,129.996,134.532,138.256,143.319,147.7,152.08,155.236,159.616,162.16400000000002,167.244,171.624,177.034,182.22799999999998,187.256,192.46,197.556,202.759,207.325,211.706,216.086,218.63400000000001,223.653,226.808,230.483,233.031,241.195,245.575,248.825,254.127,258.507,261.055,265.436,273.599,281.762,286.98" svgx:width="0.38,0.54,0.38,0.29,0.45,0.45,0.32,0.45,0.55,0.32,0.38,0.55,0.38,0.54,0.45,0.54,0.55,0.45,0.38,0.55,0.45,0.45,0.32,0.45,0.26,0.55,0.45,0.55,0.53,0.55,0.53,0.52,0.53,0.45,0.45,0.45,0.26,0.55,0.32,0.38,0.26,0.83,0.45,0.32,0.54,0.45,0.26,0.45,0.83,0.83,0.52,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">surfactants such as cetyl and dodecyl trimethylammo-</text>
   <text y="335.332" x="56.692,62.101,64.649,69.951,78.085,81.637,86.733,90.408,95.503,103.667,106.215,111.418,115.828,119.338,126.168,130.676,134.39999999999998,137.933,140.785,145.881,151.183,156.592,161.786,165.316,168.472,173.568,177.051,182.147,186.557,189.977,192.525,197.935,201.091,205.471,209.852,212.988,216.567,221.045,225.533,229.914,235.30399999999997,238.847,243.227,247.921,252.302,254.85,260.259,264.032,267.168,270.708,275.089,277.637,282.536,286.917" svgx:width="0.55,0.26,0.54,0.83,0.55,0.52,0.38,0.52,0.83,0.26,0.53,0.45,0.55,0.7,0.45,0.38,0.55,0.29,0.52,0.54,0.55,0.53,0.55,0.32,0.52,0.55,0.52,0.45,0.55,0.26,0.55,0.32,0.45,0.45,0.32,0.55,0.45,0.46,0.45,0.55,0.55,0.45,0.48,0.45,0.26,0.55,0.38,0.32,0.55,0.45,0.26,0.5,0.45,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">nium bromide was found to be intact even against alka-</text>
   <text y="347.35" x="56.692,59.24,61.788,67.197,71.607,79.483,84.784,89.165,94.369,98.044,103.14,105.788,110.169,113.942,116.49,120.214,128.125" svgx:width="0.26,0.26,0.55,0.45,0.55,0.54,0.45,0.53,0.38,0.52,0.26,0.45,0.38,0.26,0.38,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">line hydrolysis [</text>
   <text y="347.35" x="131.3,136.199" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">82</text>
   <text y="347.35" x="141.107,144.243,152.163,156.543,161.953,167.147,175.067,180.163,182.711,187.807,192.187,196.568,200.948,205.329,209.102,212.875,215.423,220.519,223.067,227.477,235.445,242.276,244.824,247.979,253.27100000000002,261.184,266.485,270.258,274.668,282.557,287.653" svgx:width="0.32,0.55,0.45,0.55,0.53,0.55,0.52,0.26,0.52,0.45,0.45,0.45,0.45,0.38,0.38,0.26,0.52,0.26,0.45,0.55,0.7,0.26,0.32,0.54,0.55,0.54,0.38,0.45,0.55,0.52,0.29" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">] and bioaccessible with use of</text>
   <text y="359.312" x="56.692,59.847,63.522,66.07,70.451,74.832,79.312,81.86,86.554,89.102,93.483,97.863,102.244,105.919,111.117,113.665,117.38900000000001,121.208,124.363,132.526,136.907,142.111,144.659,150.064,158.19799999999998,162.026,166.407,171.708,176.089,178.637,184.047,187.183,191.053" svgx:width="0.32,0.38,0.26,0.45,0.45,0.45,0.26,0.48,0.26,0.45,0.45,0.45,0.38,0.52,0.26,0.38,0.55,0.32,0.83,0.45,0.53,0.26,0.54,0.83,0.55,0.45,0.54,0.45,0.26,0.55,0.32,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">triacylglycerols (medium chain) [</text>
   <text y="359.312" x="194.229,199.129" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">83</text>
   <text y="359.312" x="204.036,207.192,209.348,213.107,218.615,223.711,226.259,230.739,238.902,243.283,246.958,249.506,253.916,257.725,265.888,268.436,272.817,277.198,279.745,282.293,286.674" svgx:width="0.32,0.22,0.55,0.56,0.52,0.26,0.45,0.83,0.45,0.38,0.26,0.45,0.55,0.83,0.26,0.45,0.45,0.26,0.26,0.45,0.38" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">]. Polymeric micelles</text>
   <text y="371.331" x="56.692,61.788,64.63,69.164,73.545,78.847,82.522,86.902,92.204,100.459,103.007,108.397,112.875,119.705,124.086,127.842,132.252,136.687,141.782,146.163,149.936,153.185,158.281,165.111,169.492,174.68599999999998,179.207,186.038,188.586,191.741,197.03300000000002,201.601,206.697,211.185,215.566,219.29,223.768,228.668,233.568,237.205,240.057,245.153,247.701,252.89499999999998,257.388,259.936,265.346,269.803,273.478,277.859,282.389,286.162" svgx:width="0.52,0.29,0.55,0.45,0.54,0.38,0.45,0.54,0.83,0.26,0.55,0.55,0.7,0.45,0.38,0.45,0.55,0.52,0.45,0.38,0.32,0.52,0.7,0.45,0.53,0.55,0.7,0.26,0.32,0.54,0.55,0.52,0.46,0.45,0.38,0.55,0.5,0.5,0.36,0.29,0.52,0.26,0.53,0.55,0.26,0.55,0.45,0.38,0.45,0.45,0.38,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">of curcumin were bestowed with over 55-fold increase</text>
   <text y="383.349" x="56.692,59.24,64.63,68.427,73.523,76.071,81.167,85.548,90.036,94.417,96.965,99.513,103.893,108.989,111.537,114.085,116.633,119.789,124.199,128.069" svgx:width="0.26,0.55,0.55,0.52,0.26,0.52,0.45,0.46,0.45,0.26,0.26,0.45,0.52,0.26,0.26,0.26,0.32,0.45,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">in bioavailability [</text>
   <text y="383.349" x="131.243,136.143" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">84</text>
   <text y="383.349" x="141.05,144.206,146.362,150.121,153.385,158.77499999999998,162.594,166.367,168.915,177.164,179.712,182.26,186.641,190.36499999999998,194.115,196.663,199.211,204.62,209.001,213.05,215.20600000000002,218.946,222.102,226.482,234.645,239.741,244.628,247.176,250.027,254.408,259.798,263.62,266.168,271.264,275.644,280.848,285.333" svgx:width="0.32,0.22,0.55,0.33,0.55,0.55,0.38,0.26,0.83,0.26,0.26,0.45,0.38,0.55,0.26,0.26,0.55,0.45,0.38,0.22,0.55,0.32,0.45,0.83,0.52,0.49,0.26,0.29,0.45,0.55,0.55,0.26,0.52,0.45,0.53,0.45,0.53" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">]. In similar lines, tamoxifen loaded</text>
   <text y="395.311" x="56.692,64.14,69.647,73.37100000000001,78.462,81.618,85.391,87.939,92.221,96.631,101.65,106.94200000000001,108.907,113.807,118.70700000000001,123.704,129.113,137.276,140.412,145.474,148.022,153.432,158.733,161.281,166.377,168.925,172.177,176.557,181.75099999999998,186.803,191.184,195.564,198.112,200.66,205.682,210.885,214.56,219.656,222.204,224.752,227.604,231.985,235.66,240.151,243.306,245.854,250.95,256.34,261.411,266.311,271.211,274.778,277.63,282.726,285.274" svgx:width="0.76,0.56,0.38,0.55,0.32,0.38,0.26,0.44,0.45,0.55,0.54,0.55,0.5,0.5,0.55,0.55,0.83,0.32,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.45,0.53,0.55,0.45,0.45,0.26,0.26,0.55,0.53,0.38,0.52,0.26,0.26,0.29,0.45,0.38,0.45,0.32,0.26,0.52,0.55,0.55,0.5,0.5,0.36,0.29,0.52,0.26,0.53" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">NEs (size &lt; 47 nm) inhibited cell proliferation 20-fold</text>
   <text y="407.33" x="56.692,61.386,65.061,69.442,73.822,76.978,81.467,85.191,88.384,92.764,98.248,103.44200000000001,106.696,109.244,114.653,119.111,122.786,127.167,131.697,135.47,139.851,145.045,148.365,152.746,157.126,159.674,162.222,165.543,169.924,175.128,180.224,185.427,188.674,193.77,197.543,200.091,203.815,207.156,212.056,215.623,218.475,223.654,226.202,231.396,234.709,239.403,243.078,247.459,251.839,254.995,259.375,263.099,266.401,268.949,274.339,277.683,280.838,286.14" svgx:width="0.48,0.38,0.45,0.45,0.32,0.45,0.38,0.55,0.45,0.55,0.53,0.55,0.26,0.55,0.45,0.38,0.45,0.45,0.38,0.45,0.53,0.55,0.45,0.45,0.26,0.26,0.55,0.45,0.53,0.52,0.53,0.32,0.52,0.38,0.26,0.38,0.55,0.5,0.36,0.29,0.52,0.26,0.53,0.55,0.48,0.38,0.45,0.45,0.32,0.45,0.38,0.55,0.26,0.55,0.55,0.32,0.54,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">greater and increased cell apoptosis 4-fold greater in the</text>
   <text y="419.348" x="56.692,64.238,70.765,76.576,80.143,85.043,89.94300000000001,92.976,98.072,101.747,106.128,110.664,114.437,117.573,120.528,124.909,129.373,134.782,139.163,143.544,147.268,150.179,154.56,158.94,161.488,164.036,167.017,169.565,172.113,177.523,181.933,184.876" svgx:width="0.77,0.67,0.59,0.36,0.5,0.5,0.55,0.52,0.38,0.45,0.45,0.38,0.32,0.55,0.45,0.45,0.55,0.45,0.45,0.38,0.55,0.45,0.45,0.26,0.26,0.55,0.26,0.26,0.55,0.45,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">HTB-20 breast cancer cell line [</text>
   <text y="419.348" x="188.049,192.949" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">85</text>
   <text y="419.348" x="197.913,201.069" svgx:width="0.32,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">].</text>
   <text y="431.31" x="64.686,72.339,76.014,80.395,82.943,86.853,91.234,96.437,104.601,107.149,112.558,115.106,118.879,122.035,125.71,130.09,133.246,135.794,141.052,146.442,150.294,155.39,158.232,162.086,171.17,176.658,180.568,185.663,188.50500000000002,192.36,196.74,201.121,205.501,208.049,213.145,217.021,222.225,227.321,230.996,233.544,238.953,243.363,247.238,254.196,258.01,261.685,266.066,269.916,275.218,277.766,280.921,285.302" svgx:width="0.78,0.38,0.45,0.26,0.55,0.45,0.53,0.83,0.26,0.55,0.26,0.38,0.32,0.38,0.45,0.32,0.26,0.52,0.55,0.55,0.52,0.29,0.55,0.93,0.56,0.55,0.52,0.29,0.55,0.45,0.45,0.45,0.26,0.52,0.38,0.53,0.52,0.38,0.26,0.55,0.45,0.55,0.71,0.55,0.38,0.45,0.38,0.54,0.26,0.32,0.45,0.53" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">Oral administration of ME of cyclosporine A resulted</text>
   <text y="443.328" x="56.692,59.24,64.63,68.144,70.692,76.102,80.482,84.157,88.538,93.089,96.862,101.242,106.436,109.927,115.023,117.571,122.667,127.047,131.536,135.916,138.464,141.012,145.393,150.489,153.037,155.585,158.133,161.288,165.698,169.228,176.059,178.607,181.762,187.054,190.602,196.011,201.107,204.243,207.78,215.943,220.324,225.733,230.143,233.632,237.405,239.953,245.157,249.567,253.021,257.402,260.253,263.105,267.648,272.028,275.301,279.025,282.558,285.106" svgx:width="0.26,0.55,0.55,0.26,0.55,0.45,0.38,0.45,0.45,0.38,0.45,0.53,0.55,0.52,0.26,0.52,0.45,0.46,0.45,0.26,0.26,0.45,0.52,0.26,0.26,0.26,0.32,0.45,0.55,0.7,0.26,0.32,0.54,0.55,0.55,0.52,0.32,0.55,0.83,0.45,0.55,0.45,0.55,0.38,0.26,0.53,0.45,0.55,0.45,0.29,0.29,0.45,0.45,0.32,0.38,0.55,0.26,0.55" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">in increased bioavailability with not many side effects in</text>
   <text y="455.347" x="56.692,61.994,66.374,71.578,75.959,79.114,81.662,86.072,90.992,93.54,101.703,106.907,111.287,113.835,117.51,121.891,127.08500000000001,131.981,137.184,141.565,144.721,147.268,151.767,157.176,160.441,164.165,169.058" svgx:width="0.54,0.45,0.53,0.45,0.32,0.26,0.45,0.55,0.26,0.83,0.53,0.45,0.26,0.38,0.45,0.53,0.55,0.53,0.45,0.32,0.26,0.45,0.55,0.32,0.38,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">hepatic impaired patients [</text>
   <text y="455.347" x="172.232,177.132" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">86</text>
   <text y="455.347" x="182.04,185.176,190.033,194.414,199.823,205.017,209.933,213.706,216.861,221.242,226.338,228.886,233.296,238.166,243.37,245.918,250.412,254.185,262.349,266.759,271.615,276.819,280.494,285.796" svgx:width="0.32,0.55,0.45,0.55,0.53,0.55,0.38,0.32,0.45,0.52,0.26,0.45,0.55,0.53,0.26,0.45,0.38,0.83,0.45,0.55,0.53,0.38,0.54,0.48" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">] and stable plasma drug</text>
   <text y="467.309" x="56.692,61.072,66.168,71.578,75.959,80.339,85.749,89.007,92.682,97.063,100.218,102.766,107.862,113.272,116.99600000000001,122.23,129.06,133.441,137.116,141.526,146.665,154.828,159.209,161.757,167.166,170.322,174.702,177.25,182.66,187.04,192.23399999999998,197.462,200.01,205.39999999999998,210.501,214.176,218.557,223.966,228.347,230.895,236.07,238.618,246.782,251.985,256.366,258.914,262.589,266.969,272.163,277.343,282.546,286.927" svgx:width="0.45,0.52,0.55,0.45,0.45,0.55,0.32,0.38,0.45,0.32,0.26,0.52,0.55,0.38,0.55,0.7,0.45,0.38,0.45,0.55,0.83,0.45,0.26,0.55,0.32,0.45,0.26,0.55,0.45,0.53,0.55,0.26,0.55,0.55,0.38,0.45,0.55,0.45,0.26,0.55,0.26,0.83,0.53,0.45,0.26,0.38,0.45,0.53,0.55,0.53,0.45,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">concentrations were maintained in renal impaired pa-</text>
   <text y="479.327" x="56.692,59.847,62.395,66.776,72.186,75.515,79.239,82.375" svgx:width="0.32,0.26,0.45,0.55,0.32,0.38,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">tients [</text>
   <text y="479.327" x="85.549,90.449" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">87</text>
   <text y="479.327" x="95.356,98.512,100.668,103.804,111.458,115.133,119.513,122.061,125.178,129.558,134.762,139.966,142.514,145.062,149.442,153.921,157.076,159.624,164.72,170.11,173.253,178.349,181.191,184.308,188.689,193.069,197.121,201.609,205.989,211.193,213.741,216.289,221.385,223.933,227.111,229.659,234.755,239.136,244.339,248.72,253.914,257.102,264.55,270.057,273.781,276.945,282.246,286.752" svgx:width="0.32,0.22,0.55,0.78,0.38,0.45,0.26,0.55,0.45,0.53,0.53,0.26,0.26,0.45,0.45,0.32,0.26,0.52,0.55,0.55,0.52,0.29,0.55,0.45,0.45,0.38,0.46,0.45,0.53,0.26,0.26,0.52,0.26,0.55,0.26,0.52,0.45,0.53,0.45,0.53,0.55,0.76,0.56,0.38,0.55,0.54,0.45,0.38" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">]. Oral application of carvedilol loaded NEs has</text>
   <text y="491.346" x="56.692,61.896,64.444,68.217,73.42,75.968,80.349,84.729,89.233,94.427,97.681,100.837,107.667,112.763,116.33,119.281,124.377,126.925,132.119,135.382,138.234,142.753,146.526,149.681,154.062,157.786,161.065,164.74,169.12,171.668,176.049,180.568,184.341,188.751,192.02,197.223,200.898,205.994,208.846,211.394,213.942,218.352,221.67,226.051,231.46,236.654,239.926,243.699,248.203,252.691,257.071,260.746,265.21,267.758,270.993,273.845,278.941,281.489,286.693" svgx:width="0.53,0.26,0.38,0.53,0.26,0.45,0.45,0.45,0.53,0.55,0.32,0.7,0.52,0.36,0.29,0.52,0.26,0.53,0.55,0.29,0.45,0.38,0.32,0.45,0.38,0.55,0.38,0.45,0.26,0.45,0.45,0.38,0.45,0.55,0.53,0.38,0.52,0.29,0.26,0.26,0.45,0.55,0.45,0.55,0.53,0.55,0.38,0.45,0.46,0.45,0.38,0.45,0.26,0.55,0.29,0.52,0.26,0.53,0.38" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">displayed two-fold faster release profile and several folds</text>
   <text y="503.308" x="56.692,59.24,64.649,69.03,72.705,77.086,81.637,85.41,89.82,95.073,97.621,103.011,108.339" svgx:width="0.26,0.55,0.45,0.38,0.45,0.45,0.38,0.45,0.55,0.26,0.55,0.55,0.68" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">increase in C</text>
   <text y="504.964" x="114.973,121.096,124.498" svgx:width="0.83,0.45,0.49" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:6.53px;stroke:none;">max</text>
   <text y="503.32" x="133.398,137.779,143.189,148.38299999999998,153.695,160.328,167.472,174.136,179.433" svgx:width="0.45,0.55,0.53,0.55,0.71,0.73,0.68,0.55,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">and AUC [</text>
   <text y="503.32" x="182.608,187.508" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">88</text>
   <text y="503.32" x="192.415,195.571,197.727,203.017,209.423,214.725,220.027,223.75099999999998,229.152,232.308,237.61,242.02,247.294,252.498,256.878,260.553,263.709,266.257,270.637,276.037,278.585,282.965,286.121" svgx:width="0.32,0.22,0.55,0.67,0.54,0.54,0.38,0.55,0.32,0.54,0.45,0.55,0.53,0.45,0.38,0.32,0.26,0.45,0.54,0.26,0.45,0.32,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">]. Thus the particulate</text>
   <text y="515.338" x="56.693,61.073,69.237,74.538,77.086,80.859,83.508,86.36,88.908,93.288,98.482,104.428,108.201,112.581,116.354,119.51,123.988,132.151,135.875,141.846,146.226,149.901,154.311,160.215,165.419,169.094,174.275,178.763,183.144,188.534,194.458,197.613,202.709,208.687,213.783,218.19299999999998,224.107,227.88,233.182,238.386,242.766,246.441,248.989,254.085,257.809,263.793,266.341,271.731,277.682,280.838,286.14" svgx:width="0.45,0.83,0.54,0.26,0.38,0.26,0.29,0.26,0.45,0.53,0.55,0.38,0.45,0.38,0.32,0.45,0.83,0.38,0.55,0.45,0.38,0.45,0.55,0.53,0.38,0.52,0.46,0.45,0.55,0.55,0.32,0.52,0.55,0.52,0.45,0.55,0.38,0.54,0.53,0.45,0.38,0.26,0.52,0.38,0.55,0.26,0.55,0.55,0.32,0.54,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">emulsified systems are proven to be superior in the</text>
   <text y="527.357" x="56.693,59.848,63.523,67.904,72.284,75.44,83.603,88.1,93.51,96.646,101.707,106.802,109.644,114.689,119.07,123.451,127.125,130.281,134.662,137.21,142.60000000000002,147.685,152.065,154.613,157.161,165.325,169.795,175.205,178.469,182.19299999999998,187.257,190.412,195.714,200.81,206.112,210.898,216.19,221.216,224.372,229.674,234.054,238.464,243.496,250.327,254.707,258.382,262.79200000000003,267.818,272.914,276.589,280.969,283.517,286.065" svgx:width="0.32,0.38,0.45,0.45,0.32,0.83,0.45,0.55,0.32,0.55,0.52,0.29,0.55,0.45,0.45,0.38,0.32,0.45,0.26,0.55,0.55,0.45,0.26,0.26,0.83,0.45,0.55,0.32,0.38,0.55,0.32,0.54,0.52,0.54,0.48,0.54,0.55,0.32,0.54,0.45,0.45,0.55,0.7,0.45,0.38,0.45,0.55,0.52,0.38,0.45,0.26,0.26,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">treatment of certain ailments though they were orally</text>
   <text y="539.319" x="56.693,61.073,66.277,74.44,76.988,82.488,85.036,88.809,91.964,96.345,100.02,104.401,109.604" svgx:width="0.45,0.53,0.83,0.26,0.55,0.26,0.38,0.32,0.45,0.38,0.45,0.53,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">administered.</text>
   <text y="563.357" x="56.693,62.801,68.692,74.697,79.301,82.082,87.974,92.372,95.153,101.045" svgx:width="0.59,0.57,0.58,0.45,0.27,0.57,0.43,0.27,0.57,0.58" style="fill:rgb(19,20,19);font-family:CvblvlAdvTTaf7f9f4f.B;font-size:10.3px;stroke:none;">Conclusion</text>
   <text y="575.32" x="56.693,65.777,71.285,74.852,82.375,87.882,91.60600000000001,94.677,99.058,102.733,107.143,110.154,113.31,118.612,123.02199999999999,126.085,134.248,139.344,143.117,146.253,149.329,154.533,158.914,164.323,168.704,176.867,179.415,183.825,186.917,191.297,196.707,201.90099999999998,204.946,210.355,215.451,219.94,224.32,226.868,229.947,234.328,239.532,244.735,249.116,253.589,256.137,258.685,264.094,268.798,271.844,277.048,279.596,283.976,286.981" svgx:width="0.93,0.56,0.36,0.76,0.56,0.38,0.55,0.45,0.38,0.45,0.55,0.32,0.54,0.45,0.55,0.83,0.52,0.38,0.32,0.55,0.53,0.45,0.55,0.45,0.83,0.26,0.45,0.55,0.45,0.55,0.53,0.55,0.55,0.52,0.46,0.45,0.26,0.55,0.45,0.53,0.53,0.45,0.45,0.26,0.26,0.55,0.48,0.55,0.53,0.26,0.45,0.32,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">ME/NEs are the most dynamic and novel appealing plat-</text>
   <text y="587.338" x="56.693,59.545,64.641,68.316,76.479,80.203,84.756,87.608,92.704,96.428,100.8,106.004,111.175,116.271,119.946,122.494,126.904,131.302,135.074,140.17,142.718,148.02,153.116,155.664,160.07399999999998,164.58,172.743,177.839,180.387,184.768,187.923,190.471,194.968,198.69199999999998,203.131,209.961,212.509,215.665,220.957,225.468,229.848,234.64,239.844,244.403,248.784,251.939,256.32,261.514,266.003,269.159,274.46,278.841,282.516,286.896" svgx:width="0.29,0.52,0.38,0.83,0.38,0.55,0.29,0.52,0.38,0.55,0.53,0.52,0.52,0.38,0.26,0.45,0.55,0.38,0.52,0.26,0.54,0.52,0.26,0.45,0.55,0.83,0.52,0.26,0.45,0.32,0.26,0.45,0.38,0.55,0.7,0.26,0.32,0.54,0.55,0.45,0.49,0.53,0.45,0.45,0.32,0.45,0.53,0.55,0.32,0.54,0.45,0.38,0.45,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">forms for poorly soluble moieties with expected thera-</text>
   <text y="599.357" x="56.693,61.897,66.277,71.579,74.735,77.282,81.692,86.967,92.063,97.364,100.52,104.901,109.997,118.262,122.642,126.415,128.571,133.796,137.059,142.449,147.685,152.173,154.721,159.102,165.96200000000002,171.156,176.252,179.09400000000002,184.365,187.521,192.822,197.232,202.45,205.302,209.682,214.063,217.36,219.51600000000002,224.731,229.935,234.425,238.913,243.294,245.842,250.938,256.141,264.305,268.685,274.223,277.35900000000004,282.557,287.653" svgx:width="0.53,0.45,0.54,0.32,0.26,0.45,0.55,0.52,0.54,0.32,0.45,0.52,0.83,0.45,0.38,0.22,0.55,0.33,0.55,0.55,0.46,0.26,0.45,0.7,0.55,0.52,0.29,0.55,0.32,0.54,0.45,0.55,0.29,0.45,0.45,0.32,0.22,0.55,0.53,0.45,0.46,0.45,0.26,0.52,0.53,0.83,0.45,0.55,0.32,0.55,0.52,0.29" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">peutic outcomes. In view of the fact, development of</text>
   <text y="611.319" x="56.693,65.777,71.285,74.852,82.375,87.882,91.60600000000001,94.847,97.395,101.119,104.315,109.724,114.82,117.95599999999999,121.153,125.533,130.923,134.136,138.516,143.037,146.81,151.22,154.375,157.531,162.029,165.802,170.702,173.878,176.73,181.826,185.54999999999998,188.732,191.887,197.189,201.599,204.776,207.628,212.724,216.399,224.562,229.864,232.412,236.793,239.948,245.044,248.719,252.44299999999998,255.744,262.574,267.876,272.354,276.029,280.41,282.958,288.367" svgx:width="0.93,0.56,0.36,0.76,0.56,0.38,0.55,0.26,0.38,0.55,0.55,0.52,0.32,0.55,0.45,0.55,0.55,0.45,0.45,0.38,0.45,0.55,0.32,0.45,0.38,0.5,0.55,0.29,0.52,0.38,0.55,0.32,0.54,0.45,0.55,0.29,0.52,0.38,0.83,0.54,0.26,0.45,0.32,0.52,0.38,0.38,0.55,0.7,0.54,0.45,0.38,0.45,0.26,0.55,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">ME/NEs is not an easy task for the formulators wherein,</text>
   <text y="623.337" x="56.693,59.848,65.15,69.531,73.941,77.67,81.345,85.725,90.929,96.322,98.87,102.545,106.955,110.665,115.967,119.122,127.285,132.381,136.154,139.29,143.094,147.474,150.63,153.785,158.166,163.673,166.829,169.377,174.473,179.863,183.629,188.725,194.115,197.858,201.631,206.012,208.56,213.109,217.49,220.645,223.193,228.289,233.67899999999997,237.487,241.868,247.277,252.47099999999998,256.253,261.555,265.328,269.708,274.403,278.81300000000005,282.559,287.655" svgx:width="0.32,0.54,0.45,0.45,0.55,0.38,0.45,0.53,0.54,0.26,0.38,0.45,0.55,0.54,0.32,0.83,0.52,0.38,0.32,0.55,0.45,0.32,0.32,0.45,0.55,0.32,0.26,0.52,0.55,0.55,0.52,0.55,0.55,0.38,0.45,0.26,0.45,0.45,0.32,0.26,0.52,0.55,0.55,0.45,0.55,0.53,0.55,0.54,0.38,0.45,0.48,0.45,0.55,0.52,0.29" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">they require utmost attention on selection and usage of</text>
   <text y="635.356" x="56.693,61.073,65.454,69.129,72.804,75.352,79.824,83.499,87.272,90.839,93.387,98.796,101.952,106.332,111.119,114.794,119.174,124.584,127.843,131.567,135.043,140.139,142.98100000000002,146.438,149.594,154.896,159.30599999999998,162.709,167.913,172.294,174.841,177.389,181.878,186.35,190.025,194.435,197.803,201.576,205.956,209.729,212.885,217.362,225.526,227.68200000000002,231.082,237.488,242.79,248.092,252.116,254.27200000000002,257.671,260.827,266.129,268.677,272.401,275.926,280.307,283.982,286.982" svgx:width="0.45,0.45,0.38,0.38,0.26,0.45,0.38,0.38,0.36,0.26,0.55,0.32,0.45,0.48,0.38,0.45,0.55,0.32,0.38,0.55,0.52,0.29,0.55,0.32,0.54,0.45,0.55,0.53,0.45,0.26,0.26,0.46,0.45,0.38,0.45,0.55,0.38,0.45,0.38,0.32,0.45,0.83,0.22,0.55,0.67,0.54,0.54,0.38,0.22,0.55,0.32,0.54,0.26,0.38,0.55,0.45,0.38,0.32,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">carriers/integrants of the delivery system. Thus, this art-</text>
   <text y="647.318" x="56.693,59.241,63.621,66.169,70.579,76.989,82.193,85.868,90.964,93.512,96.06,98.912,101.46,105.84,110.221,112.769,115.317,119.72699999999999,126.2,131.403,135.078,139.459,143.321,147.702,153.111,156.418,160.142,166.565,169.721,175.023,179.433,185.841,188.389,193.798,196.65,201.746,205.421,213.677,218.058,221.214,223.762,228.858,234.248,240.72,245.816,251.20600000000002,257.614,261.995,266.375,270.05,273.725,276.273,280.745,284.42,288.399" svgx:width="0.26,0.45,0.26,0.45,0.55,0.53,0.38,0.52,0.26,0.26,0.29,0.26,0.45,0.45,0.26,0.26,0.45,0.55,0.53,0.38,0.45,0.38,0.45,0.55,0.32,0.38,0.55,0.32,0.54,0.45,0.55,0.26,0.55,0.29,0.52,0.38,0.83,0.45,0.32,0.26,0.52,0.55,0.55,0.52,0.55,0.55,0.45,0.45,0.38,0.38,0.26,0.45,0.38,0.38,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">icle prolifically presents the information on carriers,</text>
   <text y="659.336" x="56.693,61.073,66.169,74.333,79.536,84.632,88.497,91.045,94.201,96.749,101.845,107.235,111.402,115.782,121.192,126.386,130.508,133.663,138.965,143.346,145.985,149.709,153.751,156.299,161.709,165.276,169.764,172.312,175.468,179.143,184.239,188.391,192.771,198.181,203.375,207.497,210.045,215.454,219.021,223.51,226.149,230.637,235.733,239.812,242.664,247.965,253.375,257.841,260.996,263.544,268.64,274.05,277.823,279.979,284.09,287.353" svgx:width="0.45,0.52,0.83,0.53,0.52,0.38,0.26,0.32,0.26,0.52,0.55,0.55,0.45,0.55,0.53,0.55,0.32,0.54,0.45,0.26,0.38,0.55,0.26,0.55,0.36,0.46,0.26,0.32,0.38,0.52,0.55,0.45,0.55,0.53,0.55,0.26,0.55,0.36,0.46,0.26,0.46,0.52,0.55,0.29,0.54,0.55,0.45,0.32,0.26,0.52,0.55,0.38,0.22,0.55,0.33,0.32" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">composition and their in-vitro and in-vivo functions. It</text>
   <text y="671.355" x="56.693,63.523,68.031,71.75500000000001,74.778,78.551,83.852,88.233,92.613,96.994,100.767,104.655,107.506,112.808,115.35600000000001,118.374,121.53,126.626,129.599,132.147,134.695,137.243,142.545,146.318,149.473,153.241,157.621,160.777,165.18699999999998,168.151,173.247,178.637,181.644,184.799,190.101,194.511,197.461,205.624,208.172,212.552,217.02,219.568,222.116,224.664,229.096,233.476,236.632,239.18,244.276,249.666,252.68,257.776,260.618,263.622,268.825,273.206,276.881,280.12,282.668,287.048" svgx:width="0.7,0.45,0.38,0.55,0.38,0.54,0.45,0.45,0.45,0.38,0.38,0.29,0.54,0.26,0.55,0.32,0.52,0.55,0.26,0.26,0.26,0.54,0.38,0.32,0.38,0.45,0.32,0.45,0.55,0.52,0.55,0.55,0.32,0.54,0.45,0.55,0.83,0.26,0.45,0.45,0.26,0.26,0.26,0.44,0.45,0.32,0.26,0.52,0.55,0.55,0.52,0.29,0.55,0.53,0.45,0.38,0.32,0.26,0.45,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">was successful to illustrate on the micellization of partic-</text>
   <text y="683.316" x="56.693,61.995,64.543,68.923,72.079,76.459,80.183,84.359,91.19,93.738,96.893,102.185,106.356,108.904,114.206,122.369,124.917,130.326,134.707,137.255,141.392,145.773,150.869,156.36,159.515,163.896,169.306,172.574,176.298,180.454,184.834,190.244,195.438,199.56,203.333,208.634,213.73,217.503,221.884,227.088,232.498,236.879,242.288,245.424,249.563,252.111,257.52,260.676,265.056,268.829,271.985,274.533,279.942,284.323,286.871" svgx:width="0.54,0.26,0.45,0.32,0.45,0.38,0.55,0.7,0.26,0.32,0.54,0.55,0.26,0.54,0.83,0.26,0.55,0.45,0.26,0.55,0.45,0.52,0.55,0.32,0.45,0.55,0.32,0.38,0.55,0.45,0.55,0.53,0.55,0.38,0.54,0.52,0.38,0.45,0.53,0.54,0.45,0.55,0.32,0.55,0.26,0.55,0.32,0.45,0.38,0.32,0.26,0.55,0.45,0.26,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">ulates with luminal contents and subsequent intestinal/</text>
   <text y="695.335" x="56.693,59.241,63.621,71.785,76.988,82.28,89.916,94.296,99.392,103.165,108.261,111.936,117.14,120.295,122.843,127.939,133.349,135.505,143.151,146.414,154.577,159.781,164.162,168.542,171.678,179.321,184.417,187.25900000000001,195.081,200.177,202.725,207.821,212.202,217.503,222.01,230.174,232.722,237.102,241.483,244.031,251.604,255.985,261.394,266.588,274.168,279.264,281.812,286.908" svgx:width="0.26,0.45,0.83,0.53,0.54,0.55,0.45,0.52,0.38,0.52,0.38,0.53,0.32,0.26,0.52,0.55,0.22,0.55,0.33,0.83,0.53,0.45,0.45,0.32,0.55,0.52,0.29,0.55,0.52,0.26,0.52,0.45,0.54,0.45,0.83,0.26,0.45,0.45,0.26,0.55,0.45,0.55,0.53,0.55,0.52,0.26,0.52,0.36" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">lymph absorption. Impact of biochemical and bio-</text>
   <text y="707.354" x="56.693,61.897,67.198,71.579,75.254,83.508,87.889,92.269,96.65,101.952,105.107,107.655,112.036,116.416,118.964,122.683,127.887,131.562,134.11,139.52,143.9,146.448,151.652,154.2,158.683,162.40699999999998,166.11,171.206,176.596,180.227,184.607,189.703,193.476,198.572,202.337,207.541,210.696,213.244,218.34,223.73000000000002,227.395,231.776,237.186,242.38,246.048,251.251,253.799,257.572,262.776,267.872,271.729,274.277,277.433,279.981,285.077" svgx:width="0.53,0.54,0.45,0.38,0.83,0.45,0.45,0.45,0.54,0.32,0.26,0.45,0.45,0.26,0.55,0.53,0.38,0.26,0.55,0.45,0.26,0.53,0.26,0.45,0.38,0.55,0.52,0.55,0.55,0.45,0.52,0.38,0.52,0.38,0.53,0.32,0.26,0.52,0.55,0.55,0.45,0.55,0.53,0.55,0.53,0.26,0.38,0.53,0.52,0.38,0.26,0.32,0.26,0.52,0.55" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">pharmaceutical principles on absorption and disposition</text>
   <text y="719.315" x="56.693,61.897,66.277,69.433,72.588,76.969,80.644,86.053,89.777,94.451,99.547,102.389,106.923,116.008,121.515,125.179,132.626,138.134,141.85799999999998,146.438,153.269,157.777,161.50099999999998,166.111,171.314,174.989,179.37,183.143,187.524,192.933,196.089,200.58,205.774,210.274,217.105,221.485,224.033,226.581,231.194,236.496,240.876,244.551,248.932,251.48,256.87,261.468,264.319,269.415,273.139,277.682,280.837,286.139" svgx:width="0.53,0.45,0.32,0.32,0.45,0.38,0.55,0.38,0.55,0.52,0.29,0.55,0.93,0.56,0.36,0.76,0.56,0.38,0.55,0.7,0.45,0.38,0.55,0.53,0.38,0.45,0.38,0.45,0.55,0.32,0.45,0.53,0.55,0.7,0.45,0.26,0.26,0.55,0.54,0.45,0.38,0.45,0.26,0.55,0.55,0.29,0.52,0.38,0.55,0.32,0.54,0.45" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">patterns of ME/NEs was presented well herein for the</text>
   <text y="731.334" x="56.693,59.241,64.65,67.806,72.187,75.862,80.334,84.107,87.243,90.199,95.295,98.137,101.14,104.815,109.196,113.576,118.78,123.161,126.836,130.56,133.626,138.007,143.416,148.60999999999999,151.598,155.979,161.075,166.376,171.786,176.49,179.492,183.167,187.547,191.32,195.701,200.081,203.756,208.235,213.536,217.917,221.592,225.365" svgx:width="0.26,0.55,0.32,0.45,0.38,0.45,0.38,0.32,0.55,0.52,0.29,0.55,0.38,0.45,0.45,0.53,0.45,0.38,0.38,0.55,0.45,0.55,0.53,0.55,0.45,0.52,0.54,0.55,0.48,0.55,0.38,0.45,0.38,0.45,0.45,0.38,0.45,0.54,0.45,0.38,0.38,0.22" style="fill:rgb(19,20,19);font-family:LxbkdfAdvTT86d47313;font-size:9.8px;stroke:none;">interest of readers and young researchers.</text>
   <text y="95.358" x="304.724,309.487,313.859,318.232,320.887,324.712,328.461,330.336,334.086,336.659,338.534,342.749,346.964" svgx:width="0.63,0.58,0.58,0.35,0.51,0.5,0.25,0.5,0.34,0.25,0.56,0.56,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">Abbreviations</text>
   <text y="104.315" x="304.724,309.097,312.847,314.407" svgx:width="0.58,0.5,0.21,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">API:</text>
   <text y="104.315" x="317.934,322.306,325.584,327.849,329.409,332.761,336.36100000000005,338.627,342.684,346.667,350.019,352.202,358.292,361.644,364.921,368.514,372.414,374.679,376.239,379.516,382.869,384.444,386.758,388.318,392.301,396.358,398.54,402.133,406.19,407.75,411.343,415.325,417.59,418.86499999999995,421.17,426.007,430.845,435.217,438.967,440.24199999999996,442.486,447.323,448.883,452.941,456.923,460.981,464.653,467.93,471.208,472.783,475.027,479.085,480.645,486.735,490.327,492.592,496.575,499.852" svgx:width="0.58,0.44,0.3,0.21,0.45,0.48,0.55,0.54,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.45,0.21,0.55,0.21,0.53,0.54,0.29,0.48,0.54,0.21,0.48,0.53,0.3,0.17,0.55,0.64,0.64,0.58,0.5,0.17,0.55,0.64,0.21,0.54,0.53,0.54,0.48,0.44,0.44,0.21,0.55,0.54,0.21,0.81,0.48,0.3,0.53,0.44,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Active pharmaceutical ingredient; DDAB: Didodecyl dimethyl</text>
   <text y="113.329" x="304.724,308.077,314.167,320.257,324.239,328.221,329.781,333.681,339.756,342.084,346.142,348.324,352.307,358.396,359.956,364.014,367.606,368.881,371.167,375.772,377.332,380.767,382.042,384.263,388.868,392.22,394.95,397.215,399.398,403.38,404.94,408.923,411.188,414.877,417.607,419.872,421.432,425.414,428.767,430.342,432.564,434.829,437.012,440.364,443.642,445.907,447.18199999999996,449.459,454.146,457.499,461.249,462.524,464.766,469.454,472.731,476.788,478.971,482.953,487.011,490.993,492.553,494.113,495.673,498.973,501.276,502.836,504.396,508.453,512.435,516.493,520.475,522.035,523.595,525.155" svgx:width="0.45,0.81,0.81,0.53,0.53,0.21,0.52,0.81,0.55,0.54,0.29,0.53,0.81,0.21,0.54,0.48,0.17,0.55,0.61,0.21,0.46,0.17,0.55,0.61,0.45,0.36,0.3,0.29,0.53,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.3,0.29,0.45,0.44,0.3,0.17,0.55,0.63,0.45,0.5,0.17,0.55,0.63,0.44,0.54,0.29,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">ammonium bromide; GIT: Gastrointestinal tract; HLB: Hydrophilic lipophilic</text>
   <text y="122.343" x="304.724,308.782,312.134,313.694,317.047,321.029,324.307,327.899,329.174,331.426,336.114,340.801,345.406,350.475,353.048,357.653,362.415,366.63,367.905,370.147,374.835,378.735,384.825,388.177,392.15200000000004,394.468,398.526,402.118,406.1,410.083,416.173,419.773,422.02,426.003,428.185,432.243,435.595,439.578,441.138,444.1,447.453,449.718,451.278,455.26,459.242,461.41700000000003,463.746,467.804,471.396,475.378,478.978,481.264,485.247,489.229,495.319,498.912,502.894,506.172,507.731,511.084,513.349,517.249,519.431" svgx:width="0.54,0.45,0.21,0.45,0.53,0.44,0.48,0.17,0.55,0.63,0.63,0.61,0.67,0.34,0.61,0.63,0.56,0.17,0.55,0.63,0.52,0.81,0.45,0.53,0.55,0.54,0.48,0.53,0.53,0.81,0.48,0.55,0.53,0.29,0.54,0.45,0.53,0.21,0.4,0.45,0.3,0.21,0.53,0.53,0.29,0.55,0.54,0.48,0.53,0.48,0.55,0.53,0.53,0.81,0.48,0.53,0.44,0.21,0.45,0.3,0.52,0.29,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">balance; HUGO/GNC: Human genome organization- gene nomenclature</text>
   <text y="131.357" x="304.724,308.002,311.984,318.074,324.164,325.724,327.989,330.254,333.846,337.439,338.714,341.007,344.36,348.575,352.01,353.28499999999997,355.52,358.873,362.855,366.838,370.88800000000003,373.152,376.429,380.412,383.764,385.398,389.37300000000005,391.634,393.899,396.081,397.641,401.699,403.259,406.536,409.814,413.406,415.589,417.148,421.206,424.798,427.528,428.803,431.091,436.866,441.081,444.516,445.791,448.043,453.818,457.41,461.468,463.028,466.927,473.002,475.312,478.589,482.572,485.924,487.484,491.459,493.737,496.002,498.184,499.744,503.801,505.361,508.639,511.916,515.509,517.691,519.251,523.309,526.901,529.736" svgx:width="0.44,0.53,0.81,0.81,0.21,0.3,0.3,0.48,0.48,0.17,0.55,0.45,0.56,0.46,0.17,0.55,0.45,0.53,0.53,0.54,0.55,0.44,0.53,0.45,0.21,0.53,0.55,0.3,0.29,0.21,0.54,0.21,0.44,0.44,0.48,0.29,0.21,0.54,0.48,0.36,0.17,0.55,0.77,0.56,0.46,0.17,0.55,0.77,0.48,0.54,0.21,0.52,0.81,0.55,0.44,0.53,0.45,0.21,0.53,0.55,0.3,0.29,0.21,0.54,0.21,0.44,0.44,0.48,0.29,0.21,0.54,0.48,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">committee; LCT: Long chain triglycerides; MCT: Medium chain triglycerides;</text>
   <text y="140.314" x="304.724,310.499,315.337,319.087,320.36199999999997,322.639,328.414,332.314,333.874,336.139,337.714,339.93,343.988,346.17,350.07,354.12,356.428,358.61,362.203,364.933,366.493,369.223,371.488,374.84,378.822,382.1,385.692,386.967,389.253,395.028,398.462,401.035,405.797,409.232,411.962,413.23699999999997,415.502,421.276,422.836,426.114,428.371,432.353,435.946,442.035,445.935,447.495,450.225,451.785,455.768,459.75,462.48,465.053,469.035,472.387,476.37,480.352,483.945,490.035,493.935,495.495,498.225,499.916,503.898,507.881,510.611" svgx:width="0.77,0.64,0.5,0.17,0.55,0.77,0.52,0.21,0.3,0.21,0.55,0.54,0.29,0.52,0.54,0.55,0.29,0.48,0.36,0.21,0.36,0.3,0.45,0.53,0.44,0.48,0.17,0.55,0.77,0.46,0.34,0.63,0.46,0.36,0.17,0.55,0.77,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.34,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">MDR: Multi drug resistance; ME/NEs: Microemulsions/nanoemulsions;</text>
   <text y="149.328" x="304.724,310.499,315.187,319.402,320.67699999999996,322.923,328.698,332.598,335.875,337.435,341.418,342.693,344.976,349.739,353.091,356.526,357.801,360.056,364.819,368.171,372.154,376.136,380.194,383.546,385.729,387.993,389.553,392.831,396.731,398.291,401.643,403.908,407.50800000000004,409.832,411.392,412.952,417.01,418.57,422.62,424.912,427.642,429.907,432.09,435.99,439.267,441.532,445.432,447.615,451.207,453.937,455.212,457.511,462.506,465.941,469.293,474.13,477.565,478.84,481.095,486.09,488.272,491.625,493.2,495.438,499.03,505.12,509.02,510.58,513.31,514.87,516.82,518.38,521.972" svgx:width="0.77,0.63,0.56,0.17,0.55,0.77,0.52,0.44,0.21,0.53,0.17,0.55,0.63,0.45,0.46,0.17,0.55,0.63,0.45,0.53,0.53,0.54,0.45,0.29,0.3,0.21,0.44,0.52,0.21,0.45,0.3,0.48,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.36,0.17,0.55,0.67,0.46,0.45,0.64,0.46,0.17,0.55,0.67,0.29,0.45,0.21,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.21,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">MUC: Mucin; NLS: Nanoparticulate lipid structures; OELDS: Oral emulsified</text>
   <text y="158.342" x="304.724,306.284,307.844,311.902,313.462,317.512,319.804,323.862,327.454,329.014,330.574,333.927,337.519,339.701,343.00100000000003,345.259,347.989,351.266,353.996,356.261,359.854,365.944,368.674,369.94899999999996,372.244,375.994,379.429,384.034,385.30899999999997,387.552,391.301,395.284,396.844,400.121,403.714,405.979,409.961,413.239,414.799,418.391,422.374,425.97400000000005,428.256,432.314,433.874,437.151,440.429,444.411,445.971,447.246,449.516,453.266,456.701,460.136,461.411,463.633,467.383,470.975,473.24,474.8,478.078,481.978,483.537,487.52,489.702,493.295,497.364,501.422,505.404,507.669,511.652,515.244,516.804,518.364,521.717" svgx:width="0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.5,0.46,0.61,0.17,0.55,0.5,0.53,0.21,0.44,0.48,0.3,0.53,0.44,0.21,0.48,0.53,0.48,0.55,0.54,0.21,0.44,0.44,0.53,0.21,0.17,0.55,0.5,0.46,0.46,0.17,0.55,0.5,0.48,0.3,0.21,0.44,0.52,0.21,0.53,0.29,0.48,0.53,0.54,0.53,0.3,0.53,0.48,0.21,0.21,0.45,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">lipid delivery systems; PEG: Polyethylene glycol; RES: Reticulo-endothelial</text>
   <text y="167.357" x="304.724,307.454,310.732,313.462,315.727,319.319,325.409,326.68399999999997,328.932,332.682,338.457,341.892,343.167,345.429,349.179,352.772,356.049,359.642,363.699,365.964,369.946,372.129,374.311,380.401,383.994,388.051,389.706,393.058,395.323,398.915,402.96500000000003,405.239,407.969,411.247,413.977,416.242,419.834,425.924,428.654,429.929,432.168,435.603,439.818,443.253,444.52799999999996,446.795,450.23,454.212,458.195,460.377,462.627,464.936,468.214,472.196,475.549,477.109,481.084,483.361,485.626,487.809,489.369,493.426,494.986,498.264,501.541,505.134,507.316,508.876,512.933,516.526,519.256" svgx:width="0.36,0.44,0.36,0.3,0.48,0.81,0.17,0.55,0.5,0.77,0.46,0.17,0.55,0.5,0.48,0.44,0.48,0.54,0.3,0.53,0.29,0.29,0.81,0.48,0.54,0.21,0.45,0.3,0.48,0.54,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.46,0.56,0.46,0.17,0.55,0.46,0.53,0.53,0.29,0.3,0.55,0.44,0.53,0.45,0.21,0.53,0.55,0.3,0.29,0.21,0.54,0.21,0.44,0.44,0.48,0.29,0.21,0.54,0.48,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">system; RMS: Receptor-mediated systems; SCT: Short chain triglycerides;</text>
   <text y="176.314" x="304.724,308.159,311.512" svgx:width="0.46,0.45,0.63" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">SLN</text>
   <text y="176.314" x="316.29" svgx:width="0.17" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">’</text>
   <text y="176.314" x="317.537,320.267,321.542,323.773,327.208,331.191,332.751,334.311,338.361,340.668,342.228,343.788,347.845,349.405,353.455,355.748,359.73,363.082,367.065,371.047,375.105,378.457,380.64,382.905,384.465,387.742,389.302,392.895,395.624,396.899,399.173,402.608,408.383,411.818,416.656,421.493,425.025,426.29999999999995,428.483,431.918,435.51,437.07,439.02,441.296,447.386,448.946,452.223,454.406,458.388,461.981,468.071,471.97,473.53,476.26,477.919,479.869,483.146,484.706,488.688,492.738,494.983,499.041,501.223,505.123,509.173,511.481,515.538,519.13,520.69,522.25,525.603,529.195,531.378" svgx:width="0.36,0.17,0.55,0.46,0.53,0.21,0.21,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.53,0.45,0.53,0.53,0.54,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.36,0.17,0.55,0.46,0.77,0.46,0.64,0.64,0.46,0.17,0.55,0.46,0.48,0.21,0.26,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">s: Solid lipid nanoparticles; SMEDDS: Self microemulsifying drug delivery</text>
   <text y="185.328" x="304.724,307.454,310.732,313.462,315.727,319.319,325.409,328.139,329.414,331.71,335.145,339.907,343.342,348.179,353.017,356.452,357.727,359.999,363.434,367.027,368.587,370.537,372.755,376.738,380.09,384.073,388.055,391.647,397.813,401.713,403.273,406.003,407.563,409.513,412.79,414.35,418.333,422.38300000000004,424.685,428.743,430.925,434.825,438.875,441.183,445.24,448.833,450.392,451.952,455.305,458.897,461.08,464.38,466.637,469.367,472.645,475.375,477.64,481.232,487.322" svgx:width="0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.46,0.63,0.46,0.64,0.64,0.46,0.17,0.55,0.46,0.48,0.21,0.26,0.55,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">systems; SNEDDS: Self nanoemulsifying drug delivery systems</text>
   <text y="203.356" x="304.724,309.487,313.237,316.987,318.862,320.737,324.487,328.859,330.734,332.609,334.484,337.056,340.806,343.105,347.32,349.645,351.949,356.239,359.989,362.561,366.311,368.56,372.31,376.525,380.79999999999995,383.073,389.395,393.145,395.717,399.542,402.197,404.072,407.822,409.775" svgx:width="0.63,0.5,0.5,0.25,0.25,0.5,0.58,0.25,0.25,0.25,0.34,0.5,0.55,0.56,0.31,0.55,0.57,0.5,0.34,0.5,0.55,0.5,0.56,0.57,0.55,0.84,0.5,0.34,0.51,0.35,0.25,0.5,0.25,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">Availability of data and materials</text>
   <text y="212.314" x="304.724,309.562,312.914,315.179,318.554,320.825,323.555,327.537,330.89,333.072,334.632,338.615,342.665,344.976,348.959,352.941,355.191,357.449,360.801,364.858,368.916,370.476,372.036,375.313,378.666,382.723,384.283,387.88300000000004,390.216,392.481,396.456,398.72,400.985,404.968,406.528,409.228,411.533,414.886,417.068,419.333,420.893,424.171,425.731,429.331,431.602,434.955,437.655,439.936,443.919,447.894,450.14,454.198,457.55,459.815,463.168,465.898,469.586,471.836,474.065,475.625,478.325,480.642,484.699,488.292,492.274,495.866,498.049,501.401,503.666,507.259,511.309,513.58,517.562" svgx:width="0.64,0.45,0.3,0.45,0.55,0.36,0.53,0.45,0.29,0.21,0.53,0.54,0.55,0.53,0.53,0.3,0.55,0.45,0.54,0.54,0.21,0.21,0.44,0.45,0.54,0.21,0.48,0.55,0.3,0.53,0.55,0.3,0.53,0.21,0.36,0.55,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.55,0.45,0.36,0.55,0.53,0.53,0.55,0.54,0.45,0.3,0.45,0.36,0.48,0.3,0.55,0.21,0.36,0.55,0.54,0.48,0.53,0.48,0.29,0.45,0.3,0.48,0.54,0.55,0.53,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Data sharing not applicable to this article as no dataset is generated or</text>
   <text y="221.328" x="304.724,308.077,312.059,315.412,316.972,320.249,323.212,326.804,330.854,333.184,337.242,341.142,343.324,344.884,348.866,352.916,355.181,357.446,361.428,365.028,367.313,370.591,374.491,376.673,378.855,382.448,386.43,388.68,391.011,393.741,396.005,399.905,403.963,407.24" svgx:width="0.45,0.53,0.45,0.21,0.44,0.4,0.48,0.54,0.55,0.54,0.52,0.29,0.21,0.53,0.54,0.55,0.3,0.53,0.48,0.55,0.44,0.52,0.29,0.29,0.48,0.53,0.3,0.55,0.36,0.3,0.52,0.54,0.44,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">analyzed during the current study.</text>
   <text y="239.356" x="304.724,309.487,313.702,316.274,320.489,324.704,327.359" svgx:width="0.63,0.56,0.34,0.56,0.56,0.35,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">Authors</text>
   <text y="239.356" x="330.519" svgx:width="0.23" style="fill:rgb(19,20,19);font-family:NhwfyyAdvTT99c4c969;font-size:7.5px;stroke:none;">’</text>
   <text y="239.356" x="334.488,337.84,342.055,346.27,348.842,351.497,353.372,357.745,361.96,364.532,366.407,370.622,374.837" svgx:width="0.45,0.56,0.56,0.34,0.35,0.25,0.58,0.56,0.34,0.25,0.56,0.56,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">contributions</text>
   <text y="248.314" x="304.724,307.296,312.096,314.418,317.77,321.753,325.803,328.08,331.83,335.58,337.832,341.889,345.482,348.212,349.772,353.829,357.811,361.404,365.454,367.765,370.03,374.013,377.613,379.841,385.931,389.283,393.266,397.245,399.975,403.253,405.435,406.995,411.052,413.317,414.592,416.804,419.377,424.177,426.499,429.851,433.833,437.88300000000004,440.161,442.734,446.484,448.779,452.836,455.018,458.611,462.668,466.021,468.203,471.796,475.846,478.145,480.41,484.392,487.992,490.221,494.278,497.63,501.688,505.358,507.54,508.815,511.027,514.777,518.527,520.778,524.131,528.113" svgx:width="0.34,0.64,0.55,0.45,0.53,0.54,0.55,0.5,0.5,0.55,0.54,0.48,0.36,0.21,0.54,0.53,0.48,0.54,0.55,0.3,0.53,0.48,0.55,0.81,0.45,0.53,0.52,0.36,0.44,0.29,0.21,0.54,0.3,0.17,0.55,0.34,0.64,0.55,0.45,0.53,0.54,0.55,0.34,0.5,0.55,0.54,0.29,0.48,0.54,0.45,0.29,0.48,0.54,0.55,0.3,0.53,0.48,0.55,0.54,0.45,0.54,0.48,0.29,0.17,0.55,0.5,0.5,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">JD and PR designed the manuscript; JD and JP prepared the paper. PR and</text>
   <text y="257.328" x="304.724,308.159,311.909,314.191,316.374,319.966,323.319,324.879,328.471,333.856,337.449,341.499,343.784,347.137,351.119,355.16900000000004,357.447,361.039,365.097,366.657,368.922,372.514,376.564,378.876,381.141,385.124,388.72400000000005,390.952,397.042,400.394,404.377,408.277,411.007,414.284,416.467,418.027,422.189,424.454,425.729,427.915,430.488,435.288,437.61,440.962,444.945,448.995,451.272,454.707,458.457,460.74,464.797,466.98,470.572,475.972,478.201,480.466,484.449,488.04900000000004,490.333,492.283,493.843,497.9,501.8,503.983,507.575,510.305,511.58,513.86,518.233,519.793" svgx:width="0.46,0.5,0.55,0.29,0.48,0.45,0.21,0.48,0.72,0.48,0.54,0.55,0.45,0.53,0.54,0.55,0.48,0.54,0.21,0.3,0.48,0.54,0.55,0.3,0.53,0.48,0.55,0.81,0.45,0.53,0.52,0.36,0.44,0.29,0.21,0.54,0.3,0.17,0.55,0.34,0.64,0.55,0.45,0.53,0.54,0.55,0.46,0.5,0.55,0.54,0.29,0.48,0.72,0.55,0.3,0.53,0.48,0.55,0.26,0.21,0.54,0.52,0.29,0.48,0.36,0.17,0.55,0.58,0.21,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">SR reviewed and edited the manuscript. JD and SB drew the figures. All</text>
   <text y="266.343" x="304.724,308.076,311.976,314.241,318.223,322.206,324.388,327.08799999999997,329.442,331.624,335.217,338.569,342.619,344.862,348.215,352.197,356.247,358.525,361.877,365.935,369.992,372.175,376.157,379.509,383.102,387.152,389.479,391.744,395.726,399.326,401.611,407.701,411.053,415.036,418.936,421.666,424.943,427.125,428.685,432.743,435.008" svgx:width="0.45,0.52,0.3,0.53,0.53,0.29,0.36,0.55,0.29,0.48,0.45,0.54,0.55,0.45,0.53,0.54,0.55,0.45,0.54,0.54,0.29,0.53,0.45,0.48,0.54,0.55,0.3,0.53,0.48,0.55,0.81,0.45,0.53,0.52,0.36,0.44,0.29,0.21,0.54,0.3,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">authors read and approved the manuscript.</text>
   <text y="284.315" x="304.724,308.548,311.121,315.336,317.211,320.563,323.71299999999997,325.984,329.733,334.106,338.478,341.133,345.348,349.098,352.848,354.723,356.994,360.744,364.959,369.234,371.507,374.86,379.074,383.289,386.409,390.234,394.449,396.999,399.343,401.915,406.115,408.414,412.787,416.536,419.191,421.764,423.639,426.991,428.866,433.239,436.989,439.561" svgx:width="0.51,0.34,0.56,0.25,0.45,0.42,0.55,0.5,0.58,0.58,0.35,0.56,0.5,0.5,0.25,0.55,0.5,0.56,0.57,0.55,0.45,0.56,0.56,0.42,0.51,0.56,0.34,0.55,0.34,0.56,0.55,0.58,0.5,0.35,0.34,0.25,0.45,0.25,0.58,0.5,0.34,0.51" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">Ethics approval and consent to participate</text>
   <text y="293.329" x="304.724,309.486,313.468,315.718,317.989,321.342,325.399,329.457,331.017,332.577,335.854,339.207,343.264,344.824,348.416" svgx:width="0.63,0.53,0.3,0.55,0.45,0.54,0.54,0.21,0.21,0.44,0.45,0.54,0.21,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Not applicable.</text>
   <text y="311.357" x="304.724,309.096,313.311,319.633,324.006,327.831,330.403,332.278,336.493,340.768,343.104,344.979,349.194,351.767,355.592,358.247,362.072,365.191,367.764" svgx:width="0.58,0.56,0.84,0.58,0.51,0.34,0.25,0.56,0.57,0.55,0.25,0.56,0.34,0.51,0.35,0.51,0.42,0.34,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">Competing interests</text>
   <text y="320.314" x="304.724,308.159,312.141,315.74100000000004,317.989,321.342,325.242,327.507,331.489,335.472,337.654,340.354,342.708,346.765,350.357,353.635,355.195,358.547,360.73,364.33000000000004,366.575,368.84,372.823,376.175,378.425,380.748,383.013,386.996,390.588,393.88800000000003,396.112,400.094,403.447,406.799,410.399,412.667,416.649,420.624,422.928,426.205,430.188,436.278,440.335,443.928,446.193,447.753,451.735,455.785,458.077,459.637,463.619,465.884,469.477,471.659,475.252,477.982,480.247,482.977" svgx:width="0.46,0.53,0.48,0.55,0.45,0.52,0.3,0.53,0.53,0.29,0.36,0.55,0.54,0.48,0.44,0.21,0.45,0.29,0.48,0.55,0.3,0.53,0.45,0.3,0.55,0.3,0.53,0.48,0.44,0.55,0.53,0.45,0.45,0.48,0.55,0.53,0.53,0.55,0.44,0.53,0.81,0.54,0.48,0.3,0.21,0.53,0.54,0.55,0.21,0.53,0.3,0.48,0.29,0.48,0.36,0.3,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">The authors declare that they have no competing interests.</text>
   <text y="344.353" x="304.724,310.616,316.508,322.615,325.396,328.177,332.576,338.58,343.936" svgx:width="0.57,0.57,0.59,0.27,0.27,0.43,0.58,0.52,0.38" style="fill:rgb(19,20,19);font-family:CvblvlAdvTTaf7f9f4f.B;font-size:10.3px;stroke:none;">Publisher</text>
   <text y="344.353" x="347.925" svgx:width="0.25" style="fill:rgb(19,20,19);font-family:JvlmkfAdvTTaf7f9f4f.B;font-size:10.3px;stroke:none;">’</text>
   <text y="344.353" x="350.476,354.905,357.96,365.036,371.0,374.749" svgx:width="0.43,0.55,0.69,0.57,0.36,0.52" style="fill:rgb(19,20,19);font-family:CvblvlAdvTTaf7f9f4f.B;font-size:10.3px;stroke:none;">s Note</text>
   <text y="353.31" x="304.724,308.159,312.217,314.399,315.959,319.942,323.999,327.591,329.766,332.05,336.813,340.165,342.43,346.33,348.512,352.112,354.443,356.626,360.218,366.308,369.661,371.221,375.203,377.90299999999996,380.181,384.164,387.756,391.656,393.921,396.104,399.456,401.031,403.312,408.697,410.257,412.522,416.497,418.789,420.971,424.564,428.621,431.973,434.156,438.206,440.502,442.767,446.742,449.006,450.566,454.466,456.648,458.208,460.938,464.995,466.555,469.925,472.19,473.75,477.732,481.715,485.067,486.642,488.917,492.195,493.755,497.107,498.667,504.757,507.457,509.723,511.283" svgx:width="0.46,0.54,0.29,0.21,0.53,0.54,0.48,0.29,0.55,0.63,0.45,0.3,0.52,0.29,0.48,0.55,0.29,0.48,0.81,0.45,0.21,0.53,0.36,0.55,0.53,0.48,0.52,0.3,0.29,0.45,0.21,0.55,0.72,0.21,0.3,0.53,0.55,0.29,0.48,0.54,0.45,0.29,0.54,0.55,0.3,0.53,0.55,0.21,0.52,0.29,0.21,0.36,0.54,0.21,0.44,0.3,0.21,0.53,0.53,0.45,0.21,0.55,0.44,0.21,0.45,0.21,0.81,0.36,0.55,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Springer Nature remains neutral with regard to jurisdictional claims in</text>
   <text y="362.324" x="304.724,308.782,312.682,316.739,318.299,319.859,322.589,326.571,330.164,334.214,336.528,342.618,345.971,350.028,352.728,355.066,358.419,362.401,366.451,368.729,370.289,374.271,377.001,379.266,380.826,383.091,386.991,389.256,390.816,394.799,398.781,402.134,403.709,405.976,409.328,411.278,413.228,414.788,416.348,417.908,421.261,423.526,425.086,429.163,433.146,435.876" svgx:width="0.54,0.52,0.54,0.21,0.21,0.36,0.53,0.48,0.54,0.55,0.81,0.45,0.54,0.36,0.55,0.45,0.53,0.54,0.55,0.21,0.53,0.36,0.3,0.21,0.3,0.52,0.3,0.21,0.53,0.53,0.45,0.21,0.55,0.45,0.26,0.26,0.21,0.21,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">published maps and institutional affiliations.</text>
   <text y="380.353" x="304.724,309.487,313.702,316.274,320.489,324.704,327.329,329.669,333.959,337.784,340.356,344.106,345.981,347.856" svgx:width="0.63,0.56,0.34,0.56,0.56,0.35,0.55,0.57,0.51,0.34,0.5,0.25,0.25,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">Author details</text>
   <text y="386.022" x="304.724" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:5.0px;stroke:none;">1</text>
   <text y="389.31" x="307.389,310.824,314.176,317.454,321.354,322.914,325.179,328.479,330.803,334.785,336.735,338.966,342.716,346.699,350.051,352.234,358.324,361.676,364.954,368.546,372.446,374.711,376.271,379.548,383.016,384.591,386.815,390.25,393.527,395.087,398.68,402.662,405.94,409.532,412.262,413.537,415.785,418.357,423.12,426.555,431.242,435.615,436.89,439.142,443.514,447.497,450.849,454.902,457.167,461.15,464.502,468.559,472.459,474.642,477.994,484.084,487.984,490.278,493.871,497.463,501.056,504.648,508.241,511.833,513.1080000000001,515.393,516.953,520.936,524.993,526.553,529.906" svgx:width="0.46,0.45,0.44,0.52,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.45,0.21,0.55,0.46,0.44,0.21,0.48,0.53,0.44,0.48,0.36,0.17,0.55,0.34,0.63,0.46,0.63,0.58,0.17,0.55,0.58,0.53,0.45,0.53,0.3,0.53,0.45,0.54,0.52,0.29,0.45,0.81,0.52,0.55,0.48,0.48,0.48,0.48,0.48,0.48,0.17,0.55,0.21,0.53,0.54,0.21,0.45,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Faculty of Pharmaceutical Sciences, JNTUA, Ananthapuramu 515002, India.</text>
   <text y="394.98" x="304.724" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:5.0px;stroke:none;">2</text>
   <text y="398.324" x="307.389,312.226,315.819,319.876,323.229,325.411,327.676,333.864,337.457,341.439,343.689,345.94,349.922,351.872,354.16,357.91,361.893,365.245,367.428,373.518,376.87,380.148,383.74,387.64,389.905,391.465,394.742,397.472,398.74699999999996,401.045,404.712,406.894,408.454,411.184,415.167,419.149,422.524,424.799,428.234,431.826,433.386,436.761,439.028,442.778,446.761,450.113,452.296,458.386,461.738,465.016,468.31600000000003,470.606,474.821,478.803,480.363,481.923,485.516,489.573,493.166,494.441,496.685,500.12,501.68,503.862,507.762,511.819,515.172,517.437" svgx:width="0.64,0.48,0.54,0.45,0.29,0.3,0.81,0.48,0.53,0.3,0.55,0.53,0.26,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.36,0.17,0.55,0.49,0.29,0.21,0.36,0.53,0.53,0.45,0.55,0.46,0.48,0.21,0.45,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.44,0.55,0.56,0.53,0.21,0.21,0.48,0.54,0.48,0.17,0.55,0.46,0.21,0.29,0.52,0.54,0.45,0.3,0.21" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Department of Pharmaceutics, Krishna Teja Pharmacy College, Tirupati</text>
   <text y="407.339" x="304.724,308.317,311.909,315.501,319.094,322.686,326.279,327.554,329.782,331.342,335.324,339.382,340.942,344.294" svgx:width="0.48,0.48,0.48,0.48,0.48,0.48,0.17,0.55,0.21,0.53,0.54,0.21,0.45,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">517506, India.</text>
   <text y="403.994" x="347.868" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:5.0px;stroke:none;">3</text>
   <text y="407.339" x="350.532,354.282,358.265,361.617,363.799,369.889,373.242,376.519,380.112,384.012,386.277,387.837,391.114,393.81399999999996,396.169,401.006,402.566,405.919,407.479,410.209,411.769,415.841,419.824,421.099,423.325,426.76,428.942,430.517,432.736,436.485,439.838,443.895,449.985,453.338,456.69,460.043,462.308,466.29,467.865,470.209,473.644,476.921,480.904,484.886,488.868,490.443,492.715,496.698,498.64799999999997,500.879,504.629,508.611,511.964,514.146,520.236,523.589,526.866,530.143" svgx:width="0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.36,0.55,0.64,0.21,0.45,0.21,0.36,0.21,0.53,0.53,0.17,0.55,0.46,0.29,0.21,0.55,0.5,0.45,0.54,0.81,0.45,0.45,0.45,0.3,0.53,0.21,0.55,0.46,0.44,0.53,0.53,0.53,0.21,0.55,0.53,0.26,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.44,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Pharmaceutics Division, Sri Padmavathi School of Pharmacy,</text>
   <text y="416.353" x="304.724,308.159,309.719,311.902,315.802,319.859,323.212,325.477,327.05199999999996,329.328,332.921,336.513,340.106,343.698,347.291,350.883,352.15799999999996,354.443,356.003,359.986,364.043,365.603,368.956" svgx:width="0.46,0.21,0.29,0.52,0.54,0.45,0.3,0.21,0.55,0.48,0.48,0.48,0.48,0.48,0.48,0.17,0.55,0.21,0.53,0.54,0.21,0.45,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Tirupati 517503, India.</text>
   <text y="413.008" x="372.472" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:5.0px;stroke:none;">4</text>
   <text y="416.353" x="375.137,379.974,383.567,387.624,390.977,393.159,395.424,401.612,405.205,409.187,411.437,413.688,417.67,419.62,421.908,426.123,430.106,433.698,439.788,441.348,444.626,447.978,449.553,451.842,455.277,459.259,463.317,464.877,468.859,472.452,476.044,478.227,479.787,483.769,487.826,489.101,491.357,493.929,498.692,502.127,506.814,511.16400000000004,513.466,517.681,521.664,523.224,524.784,528.376,532.434" svgx:width="0.64,0.48,0.54,0.45,0.29,0.3,0.81,0.48,0.53,0.3,0.55,0.53,0.26,0.55,0.56,0.53,0.48,0.81,0.21,0.44,0.45,0.21,0.55,0.46,0.53,0.54,0.21,0.53,0.48,0.48,0.29,0.21,0.53,0.54,0.17,0.55,0.34,0.63,0.46,0.63,0.58,0.55,0.56,0.53,0.21,0.21,0.48,0.54,0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Department of Chemical Engineering, JNTUA College</text>
   <text y="425.31" x="304.724,308.707,310.657,312.945,316.38,320.362,324.42,325.98,329.962,333.554,337.147,339.329,340.889,344.872,348.929,350.20399999999995,352.459,356.832,360.814,364.167,368.149,370.414,374.397,377.749,381.807,385.706,387.889,391.35,397.44,401.34,403.596,407.188,410.781,414.373,417.966,421.558,425.151,426.426,428.654,430.214,434.196,438.254,439.814,443.166" svgx:width="0.53,0.26,0.55,0.46,0.53,0.54,0.21,0.53,0.48,0.48,0.29,0.21,0.53,0.54,0.17,0.55,0.58,0.53,0.45,0.53,0.3,0.53,0.45,0.54,0.52,0.29,0.45,0.81,0.52,0.55,0.48,0.48,0.48,0.48,0.48,0.48,0.17,0.55,0.21,0.53,0.54,0.21,0.45,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">of Engineering, Ananthapuramu 515002, India.</text>
   <text y="422.022" x="446.74" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:5.0px;stroke:none;">5</text>
   <text y="425.31" x="449.405,454.242,457.834,461.892,465.244,467.427,469.692,475.782,479.374,483.357,485.607,487.956,491.938" svgx:width="0.64,0.48,0.54,0.45,0.29,0.3,0.81,0.48,0.53,0.3,0.55,0.53,0.26" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Department of</text>
   <text y="434.324" x="304.724,308.474,312.456,315.809,317.991,324.081,327.434,330.711,334.304,338.204,340.469,342.028,345.306,348.15,349.42499999999995,351.608,355.823,361.598,365.348,367.652,371.867,375.849,377.409,378.969,382.562,386.619,390.21900000000005,392.483,396.466,398.416,400.704,404.454,408.436,411.789,413.971,420.061,423.414,426.691,429.968,431.243,433.529,438.216,441.494,445.551,449.143,451.326,454.678,458.736,462.088,466.13800000000003,468.451,472.044,475.636,479.228,482.821,486.413,490.006,491.28099999999995,493.509,495.069,499.051,503.109,504.669,508.021" svgx:width="0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.36,0.17,0.55,0.56,0.77,0.5,0.55,0.56,0.53,0.21,0.21,0.48,0.54,0.48,0.55,0.53,0.26,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.44,0.17,0.55,0.63,0.44,0.54,0.48,0.29,0.45,0.54,0.45,0.54,0.55,0.48,0.48,0.48,0.48,0.48,0.48,0.17,0.55,0.21,0.53,0.54,0.21,0.45,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Pharmaceutics, CMR College of Pharmacy, Hyderabad 501401, India.</text>
   <text y="439.994" x="304.724" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:5.0px;stroke:none;">6</text>
   <text y="443.339" x="307.389,312.226,315.819,319.876,323.229,325.411,327.676,333.864,337.457,341.439,343.689,345.94,349.922,351.872,354.16,357.91,361.893,365.245,367.428,373.518,376.87,380.148,383.74,387.64,389.905,391.465,394.742,398.095,399.67,401.952,406.167,410.149,413.742,419.832,421.392,424.122,426.387,428.654,431.931,433.20599999999996,435.4,438.835,441.017,444.61,448.21000000000004,450.48,454.23,455.79,459.847,463.125,466.477,470.46,472.02,475.14,478.826,481.091,485.073,488.426,492.401,494.643,498.858,502.841,504.401,505.961,509.553,513.691,517.291,519.531,523.513" svgx:width="0.64,0.48,0.54,0.45,0.29,0.3,0.81,0.48,0.53,0.3,0.55,0.53,0.26,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.48,0.52,0.3,0.21,0.44,0.45,0.21,0.55,0.56,0.53,0.48,0.81,0.21,0.36,0.3,0.29,0.44,0.17,0.55,0.46,0.29,0.48,0.48,0.55,0.5,0.21,0.54,0.44,0.45,0.53,0.21,0.42,0.48,0.3,0.53,0.45,0.53,0.55,0.56,0.53,0.21,0.21,0.48,0.54,0.48,0.55,0.53,0.26" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Department of Pharmaceutical Chemistry, Sree Vidyanikethan College of</text>
   <text y="452.353" x="304.724,308.474,312.457,315.809,317.991,324.081,327.434,330.711,333.989,335.26399999999995,337.549,340.984,342.544,344.726,348.626,352.684,356.036,358.301,359.876,362.153,365.746,369.338,372.93,376.523,380.115,383.708,384.983,387.268,388.828,392.81,396.868,398.428,401.78" svgx:width="0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.44,0.17,0.55,0.46,0.21,0.29,0.52,0.54,0.45,0.3,0.21,0.55,0.48,0.48,0.48,0.48,0.48,0.48,0.17,0.55,0.21,0.53,0.54,0.21,0.45,0.17" style="fill:rgb(0,0,0);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Pharmacy, Tirupati 517102, India.</text>
   <text y="470.324" x="304.724,308.707,312.457,315.809,319.559,321.276,324.869,328.619,332.834,334.334,336.585,340.41,344.235,346.506,351.658,355.011,357.426,361.483,365.782,369.531,371.931,374.172,377.997,381.822,385.647,389.472,391.747,396.277,399.629,402.982,406.732,411.022,413.437,417.187,421.402,422.902,425.139,428.964,432.789,435.06,439.59,443.804,446.219,447.937,449.66200000000003,451.897,455.722,459.547,463.372" svgx:width="0.53,0.5,0.45,0.5,0.23,0.48,0.5,0.56,0.2,0.55,0.51,0.51,0.55,0.69,0.45,0.32,0.54,0.56,0.5,0.32,0.55,0.51,0.51,0.51,0.51,0.55,0.6,0.45,0.45,0.5,0.56,0.32,0.5,0.56,0.2,0.55,0.51,0.51,0.55,0.6,0.56,0.32,0.23,0.23,0.55,0.51,0.51,0.51,0.51" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:7.5px;stroke:none;">Received: 24 October 2017 Accepted: 24 April 2018</text>
  </g>
  <rect style="stroke:blue;stroke-width:0.3;" x="304.724" y="481.216" height="10.8" width="131.999" title="6"/>
  <text y="481.216" class="image" id="image.6.1" width="131" height="10" x="304.724">image.6.1.305_437.481_492</text>
  <g begin="text">
   <text y="497.31" x="304.724,308.939,312.764,315.104,318.929,321.584,325.409,329.624,332.976,336.801" svgx:width="0.56,0.51,0.31,0.51,0.35,0.51,0.56,0.45,0.51,0.42" style="fill:rgb(19,20,19);font-family:DyyfnhAdvTT99c4c969;font-size:7.5px;stroke:none;">References</text>
   <text y="506.324" x="304.724,308.137,309.412,319.748,323.232,327.015,328.497,329.979,331.461,335.316,338.501,340.574,343.949,345.883,349.146,350.421,352.459,356.834,360.019,363.802,367.656,371.44,373.015,375.079,378.642,382.126,383.40099999999995,385.454,389.016,392.799,395.984,398.058,403.843,407.028,410.142,413.925,416.889,418.371,422.154,425.567,427.719,429.201,432.50100000000003,434.492,437.677,440.271,444.125,447.538,450.652,452.803,455.503,457.566,460.75,464.534" svgx:width="0.48,0.17,0.55,0.49,0.53,0.21,0.21,0.21,0.54,0.45,0.29,0.45,0.55,0.46,0.17,0.55,0.61,0.45,0.53,0.54,0.53,0.21,0.55,0.5,0.49,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.53,0.42,0.21,0.53,0.48,0.3,0.21,0.44,0.55,0.45,0.36,0.54,0.48,0.44,0.3,0.36,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">1. Kollipara S, Gandhi RK. Pharmacokinetic aspects and</text>
   <text y="506.324" x="470.551,471.955,475.78,477.695,480.659,482.062,484.136,486.138" svgx:width="0.2,0.51,0.55,0.42,0.2,0.29,0.28,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">in vitro</text>
   <text y="506.324" x="491.868" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="506.324" x="497.537,498.941,502.76599999999996,504.737,507.701,509.104,512.068" svgx:width="0.2,0.51,0.55,0.42,0.2,0.42,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">in vivo</text>
   <text y="515.339" x="319.747,322.861,326.644,328.717,330.791,334.204,335.686,338.87,341.022,342.504,346.287,350.262,352.232,356.086,359.87,362.021,365.434,369.218,371.369,372.851,376.036,377.611,379.614,381.467,385.25,387.425,389.479,390.961,392.443,396.297,397.779,401.634,403.707,407.562,410.746,413.34,416.753,420.803,422.813,424.666,428.449,430.522,436.308,440.013,441.495,444.68,446.831,448.313,452.097,455.88,458.473,459.748,461.817,465.971,469.084,471.236,474.611,476.557,480.12,483.903,487.088,489.161,495.236,497.08,500.343,501.825,505.8,507.738,511.3,512.575,514.654,518.067,521.48,524.892,528.305,529.488,532.901" svgx:width="0.44,0.53,0.29,0.29,0.48,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.54,0.53,0.3,0.48,0.53,0.3,0.21,0.45,0.21,0.55,0.26,0.53,0.29,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.17,0.55,0.58,0.44,0.3,0.45,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.21,0.53,0.55,0.5,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">correlation potential for lipid-based formulations. Acta Pharm Sin B. 2014;4:</text>
   <text y="524.353" x="319.747,323.16,326.573" svgx:width="0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">333</text>
   <text y="524.353" x="329.952" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="524.353" x="333.524,336.937,340.35" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">49.</text>
   <text y="533.31" x="304.724,308.136,309.411,319.747,323.01,326.195,329.979,334.029,335.961,338.405,339.67999999999995,341.744,345.007,348.712,352.687,354.613,357.057,358.332,360.396,364.4,368.105,369.68,371.734,374.997,376.272,378.31,382.094,385.877,389.062,392.845,396.89500000000004,398.833,402.096,403.371,405.466,408.651,410.133,414.03299999999996,415.954,419.809,421.084,423.154,427.607,431.20700000000005,433.132,436.915,438.19,440.275,443.538,446.951,448.433,450.286,452.359,455.772,461.557,465.262,466.744,469.338,470.82,472.672,475.786,477.268,481.051,485.101,487.046,490.9,492.974,496.679,500.729,502.693,506.547,509.96,511.442,512.924,516.109,519.522,521.595" svgx:width="0.48,0.17,0.55,0.46,0.45,0.53,0.54,0.55,0.34,0.17,0.55,0.46,0.52,0.53,0.55,0.34,0.17,0.55,0.56,0.52,0.21,0.55,0.46,0.17,0.55,0.53,0.53,0.45,0.53,0.54,0.55,0.46,0.17,0.55,0.45,0.21,0.52,0.55,0.54,0.17,0.55,0.63,0.48,0.55,0.53,0.17,0.55,0.46,0.48,0.21,0.26,0.29,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">2. Tang J, Sun J, Cui F, Zhang T, Liu X, He Z. Self-emulsifying drug delivery</text>
   <text y="542.324" x="319.747,322.341,325.454,328.048,330.199,333.612,339.398,342.098,344.124,345.977,349.76,351.935,353.989,355.471,361.256,365.111,367.184,370.967,374.152,375.634,379.418,383.468,385.396,389.179,391.253,394.438,396.013,398.095,401.28,405.134,407.728,411.511,413.584,417.439,419.591,421.073,424.856,428.831,430.806,434.589" svgx:width="0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.55,0.26,0.53,0.29,0.55,0.21,0.81,0.54,0.29,0.53,0.45,0.21,0.53,0.54,0.55,0.53,0.29,0.45,0.21,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">systems for improving oral absorption of</text>
   <text y="542.324" x="438.576,442.729,444.133,447.767,450.659,454.222,457.972,459.892,463.305,464.708,466.112,469.674,473.237" svgx:width="0.58,0.2,0.51,0.41,0.5,0.5,0.55,0.48,0.2,0.2,0.5,0.5,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">Ginkgo Biloba</text>
   <text y="542.324" x="478.941,482.354,485.396,487.548,489.621,492.806,495.92,498.071,500.665,501.94,504.056,508.651,510.724,514.429,518.4789999999999,520.383,524.979,528.391,529.873,531.355,534.54" svgx:width="0.48,0.43,0.3,0.29,0.45,0.44,0.3,0.36,0.17,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">extracts. Drug Deliv.</text>
   <text y="551.338" x="319.747,323.16,326.573,329.986,333.399,334.581,337.994,341.407,342.59,346.003,349.415" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">2008;15:477</text>
   <text y="551.338" x="352.8" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="551.338" x="356.371,359.784,363.197" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">84.</text>
   <text y="560.352" x="304.724,308.136,309.411,319.747,323.231,327.015,330.199,334.17400000000004,336.131,340.285,346.07,347.34499999999997,349.397,352.881,356.664,358.816,360.968,364.343,366.291,369.555,370.83,372.868,377.021,380.805,383.398,386.583,388.656,390.231,392.256,395.519,399.972,401.24699999999996,403.311,406.574,410.358,413.542,415.616,421.401,424.776,426.725,430.287,433.771,435.046,437.099,441.253,442.735,444.31,446.397,448.84,450.11499999999995,452.179,455.442,458.855,460.337,462.19,464.263,468.046,471.231,475.015,478.798,482.211,487.996,491.701,493.183,495.777,497.259,499.111,502.225,503.707,507.49,511.54,513.52,517.374,519.448,523.153" svgx:width="0.48,0.17,0.55,0.49,0.53,0.45,0.53,0.55,0.58,0.81,0.17,0.55,0.49,0.53,0.3,0.3,0.45,0.55,0.46,0.17,0.55,0.58,0.53,0.36,0.45,0.29,0.21,0.55,0.46,0.63,0.17,0.55,0.46,0.53,0.45,0.29,0.81,0.45,0.55,0.5,0.49,0.17,0.55,0.58,0.21,0.21,0.55,0.34,0.17,0.55,0.46,0.48,0.21,0.26,0.29,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">3. Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Self-nanoemulsifying drug</text>
   <text y="569.309" x="319.747,323.602,327.015,328.497,329.979,333.163,336.576,338.65,341.95,343.898,346.491,349.605,352.198,354.35,357.763,363.83799999999997,365.667,367.52,370.783,375.307,378.57,383.166,387.762,391.025,392.97499999999997,395.033,398.817,400.767,402.857,405.009,408.792,412.392,414.309,418.164,421.947,425.73,427.804,429.286,432.586,434.548,439.664,442.849,445.0,448.413,450.486,452.56,455.153,458.937,460.419,464.123,467.978,469.46,473.06,475.026,478.881,480.954,484.139,487.993,491.406,493.48,495.332,497.405,501.11,502.592,504.842,506.943,508.796,510.278,513.463,516.648,520.431,524.214,527.997,529.479" svgx:width="0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.55,0.26,0.46,0.63,0.46,0.64,0.64,0.46,0.26,0.55,0.53,0.26,0.55,0.3,0.53,0.48,0.55,0.54,0.53,0.53,0.29,0.21,0.44,0.55,0.72,0.45,0.3,0.48,0.29,0.29,0.36,0.53,0.21,0.52,0.54,0.21,0.48,0.55,0.54,0.29,0.45,0.54,0.48,0.29,0.26,0.29,0.52,0.21,0.3,0.55,0.26,0.21,0.45,0.45,0.53,0.53,0.53,0.21,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">delivery system (SNEDDS) of the poorly water-soluble grape-fruit flavonoid</text>
   <text y="578.323" x="319.747,324.271,327.456,329.53,331.012,334.795,338.65,342.062,345.846,347.328,351.111,352.38599999999997,354.443,358.297,361.71,364.303,365.785,369.64,373.423,374.698,376.722,379.836,383.619,386.804,388.877,392.062,395.176,397.327,400.74,402.814,404.296,407.11,410.295,412.447,413.928,417.712,421.495" svgx:width="0.63,0.45,0.29,0.21,0.53,0.54,0.48,0.53,0.21,0.53,0.17,0.55,0.54,0.48,0.36,0.21,0.54,0.53,0.17,0.55,0.44,0.53,0.45,0.29,0.45,0.44,0.3,0.48,0.29,0.21,0.4,0.45,0.3,0.21,0.53,0.53,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Naringenin: design, characterization,</text>
   <text y="578.323" x="424.856,426.259,430.084,432.056,435.019,436.423,438.496,440.499" svgx:width="0.2,0.51,0.55,0.42,0.2,0.29,0.28,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">in vitro</text>
   <text y="578.323" x="446.229,449.414,453.197" svgx:width="0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">and</text>
   <text y="578.323" x="459.212,460.616,464.441,466.355,469.319,470.723,473.687" svgx:width="0.2,0.51,0.55,0.42,0.2,0.42,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">in vivo</text>
   <text y="578.323" x="479.395,482.808,485.992,489.177,490.659,494.364,497.549,499.701,501.183,504.966,508.749,510.024,512.106,516.702,518.775,522.48" svgx:width="0.48,0.45,0.45,0.21,0.52,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.64,0.29,0.52,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">evaluation. Drug</text>
   <text y="587.338" x="319.747,324.343,327.756,329.238,330.719,333.904,335.179,337.208,340.621,344.034,347.447,350.86,352.042,355.455,358.868,360.051,363.464,366.876" svgx:width="0.64,0.48,0.21,0.21,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Deliv. 2015;22:552</text>
   <text y="587.338" x="370.318" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="587.338" x="373.889,377.302,380.715" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">61.</text>
   <text y="596.352" x="304.724,308.136,309.411,319.747,323.01,326.423,329.836,333.619,337.032,340.332,342.254,346.999,352.485,353.76,355.804,359.808,361.881,365.586,371.661,373.548,379.034,382.297,383.572,385.623,391.11,394.223,397.486,400.671,404.455,407.755,409.718,413.722,416.907,418.18199999999996,420.263,423.526,425.599,429.012,432.197,435.382,437.975,440.939,442.421,445.121,447.134,451.659,454.843,456.118,458.189,463.975,465.457,466.939,468.421,469.902,473.087,478.873,481.573,483.644,488.097,492.692,493.967,496.002,499.565,503.348,507.053,509.205,512.988,516.9630000000001,518.906,522.91,528.696" svgx:width="0.48,0.17,0.55,0.46,0.48,0.48,0.53,0.48,0.44,0.55,0.67,0.77,0.17,0.55,0.56,0.29,0.52,0.81,0.55,0.77,0.46,0.17,0.55,0.77,0.44,0.46,0.45,0.53,0.44,0.55,0.56,0.45,0.17,0.55,0.46,0.29,0.48,0.45,0.45,0.36,0.42,0.21,0.36,0.55,0.63,0.45,0.17,0.55,0.81,0.21,0.21,0.21,0.21,0.45,0.81,0.36,0.55,0.63,0.64,0.17,0.55,0.5,0.53,0.52,0.3,0.53,0.53,0.55,0.56,0.81,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">4. Feeney OM, Crum MF, McEvoy CL, Trevaskis NL, Williams HD, Pouton CW,</text>
   <text y="605.309" x="319.747,323.751,327.535,330.72,332.793,338.578,341.763,345.738,347.696,353.481,358.006,359.28099999999995,361.302,364.864,368.277,370.35,374.205,376.798,378.95,381.024,384.807,390.882,392.766,396.77,400.924,404.187,405.462,407.506,411.069,414.852,416.925,419.077,422.49,424.665,426.725,430.729,433.173,437.626,438.90099999999995,440.955,444.367,447.96700000000004,449.912,453.026,456.439,459.623,461.697,464.397,466.409,470.192,472.142,474.176,477.959,480.033,483.217,484.792,486.875,488.357,489.839,493.693,495.175,499.03,501.103,504.958,508.142,510.736,514.149" svgx:width="0.56,0.53,0.45,0.29,0.81,0.45,0.53,0.55,0.81,0.63,0.17,0.55,0.5,0.48,0.29,0.54,0.36,0.3,0.29,0.53,0.81,0.55,0.56,0.58,0.46,0.17,0.55,0.5,0.53,0.29,0.3,0.48,0.29,0.55,0.56,0.34,0.63,0.17,0.55,0.48,0.48,0.55,0.44,0.48,0.45,0.29,0.36,0.55,0.53,0.26,0.55,0.53,0.29,0.45,0.21,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Charman WN, Bergström CAS, Porter CJH. 50 years of oral lipid-based</text>
   <text y="614.323" x="319.747,321.6,325.383,327.456,333.242,336.947,338.429,341.613,343.765,345.247,349.031,352.814,355.407,356.68199999999996,358.751,362.606,364.679,368.462,371.647,375.06,378.843,382.028,385.811,388.925,392.338,393.613,395.657,399.512,401.585,405.369,409.223,411.297,414.709,417.303,420.003,422.076,425.261,429.044,433.094,435.002,436.854,440.559,442.711,446.416,448.489,452.089,454.107,457.962,461.375,463.448,466.042,469.896,473.309,476.423,478.574,480.056,483.241,486.654,489.247,490.522,492.544,496.698,500.553,503.928,505.923,510.519,512.592,516.297,520.347,522.307,526.903,530.315,531.797,533.279" svgx:width="0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.17,0.55,0.54,0.29,0.53,0.45,0.48,0.53,0.45,0.53,0.44,0.48,0.17,0.55,0.54,0.29,0.53,0.54,0.29,0.48,0.36,0.36,0.55,0.45,0.53,0.54,0.55,0.26,0.52,0.3,0.52,0.29,0.48,0.55,0.54,0.48,0.29,0.36,0.54,0.48,0.44,0.3,0.21,0.45,0.48,0.36,0.17,0.55,0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">formulations: provenance, progress and future perspectives. Adv Drug Deliv</text>
   <text y="623.337" x="319.747,323.31,326.722,329.907,331.18199999999996,333.24,336.652,340.065,343.478,346.891,348.074,351.487,354.899,358.312,359.495,362.908,366.321" svgx:width="0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Rev. 2016;101:167</text>
   <text y="623.337" x="369.694" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="623.337" x="373.266,376.679,380.092" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">94.</text>
   <text y="632.351" x="304.724,308.137,309.412,319.748,324.493,328.198,333.983,336.798,338.28,339.85499999999996,341.914,345.398,346.673,348.717,352.279,355.692,359.476,360.958,363.772,365.845,367.327,370.027,372.074,375.337,376.61199999999997,378.65,381.913,385.697,389.48,392.893,394.375,395.857,397.432,399.456,403.831,405.106,407.166,410.429,412.581,415.766,419.179,423.033,426.446,428.021,430.07,434.074,435.349,437.44,441.594,445.448,449.303,452.488,455.673,459.456,463.43100000000004,465.389,469.543,470.818,472.872,476.876,480.66,483.844,485.697,487.549,490.734,494.518,497.93,500.18,502.238,507.724,508.99899999999997,511.025,515.55,518.734,521.919,525.104,526.586,528.068,529.55,532.963" svgx:width="0.48,0.17,0.55,0.67,0.52,0.81,0.4,0.21,0.21,0.55,0.49,0.17,0.55,0.5,0.48,0.53,0.21,0.4,0.29,0.21,0.36,0.55,0.46,0.17,0.55,0.46,0.53,0.53,0.48,0.21,0.21,0.21,0.55,0.61,0.17,0.55,0.46,0.3,0.45,0.48,0.54,0.48,0.21,0.55,0.56,0.17,0.55,0.58,0.54,0.54,0.45,0.45,0.53,0.53,0.55,0.58,0.17,0.55,0.56,0.53,0.45,0.26,0.26,0.45,0.53,0.48,0.3,0.55,0.77,0.17,0.55,0.63,0.45,0.45,0.45,0.21,0.21,0.21,0.48,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">5. Oumzil K, Benizris S, Tonelli G, Staedel C, Appavoo A, Chaffanet M, Navailles</text>
   <text y="641.308" x="319.748,322.933,324.20799999999997,326.211,329.773,332.958,335.031,337.183,340.967,344.379,345.861,349.274,355.06,358.36,360.339,363.902,365.17699999999996,367.255,370.818,375.271,377.344,380.458,381.94,385.353,388.537,391.722,394.907,398.762,400.244,403.84400000000005,405.805,409.589,413.294,416.407,417.889,421.302,425.085,427.679,429.161,433.015,436.615,438.573,440.055,441.537,445.391,446.873,450.728,453.321,454.596,456.657,460.032,461.987,465.77,469.183,474.58299999999997,476.443,480.298,483.483,485.556,488.741,492.595,494.077,497.932,504.007,505.866,507.719,511.502" svgx:width="0.45,0.17,0.55,0.5,0.45,0.29,0.3,0.53,0.48,0.21,0.48,0.81,0.44,0.55,0.5,0.17,0.55,0.5,0.63,0.29,0.44,0.21,0.48,0.45,0.45,0.45,0.54,0.21,0.48,0.55,0.53,0.52,0.44,0.21,0.48,0.53,0.36,0.21,0.54,0.48,0.55,0.21,0.21,0.54,0.21,0.54,0.36,0.17,0.55,0.45,0.55,0.53,0.48,0.72,0.55,0.54,0.45,0.29,0.45,0.54,0.21,0.54,0.81,0.55,0.26,0.53,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">L, Barthélémy P. PH-cleavable nucleoside lipids: a new paradigm for</text>
   <text y="650.322" x="319.748,322.861,326.645,330.428,332.58,334.653,338.436,339.918,341.4,342.882,346.666,350.716,352.629,354.781,358.564,362.16400000000004,364.138,366.732,368.883,372.068,375.923,377.405,378.887,380.369,382.52,385.82,387.779,391.562,393.512,395.545,397.027,398.509,402.364,403.846,407.701,409.774,413.628,416.813,419.407,422.82,426.87,428.88,432.735,436.147,437.629,439.111,442.296,445.709,447.782,451.082,453.031,455.624,458.738,461.331,463.483,466.896,472.681,475.275,476.54999999999995,478.598,482.603,486.386,489.799,495.87399999999997,497.76,503.246,506.659,510.709,512.613,516.618,520.401,523.814,529.599" svgx:width="0.44,0.53,0.53,0.3,0.29,0.53,0.21,0.21,0.21,0.53,0.54,0.55,0.3,0.53,0.48,0.55,0.36,0.3,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.56,0.53,0.48,0.81,0.55,0.77,0.48,0.54,0.55,0.56,0.53,0.48,0.81,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">controlling the stability of lipid-based delivery systems. Chem Med Chem.</text>
   <text y="659.337" x="319.748,323.161,326.574,329.986,333.399,334.582,337.995,341.408,342.59,346.003,349.416,352.829" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">2015;10:1797</text>
   <text y="659.337" x="356.202" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="659.337" x="359.773,363.186,366.599,370.012" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">801.</text>
   <text y="668.351" x="304.724,308.137,309.412,319.748,324.272,327.457,331.24,335.095,338.47,340.384,343.868,345.35,347.943,351.727,355.51,357.583,361.18300000000005,363.173,366.736,368.01099999999997,370.033,373.596,375.669,378.854,381.447,384.632,388.416,392.199,395.574,397.585,401.148,404.333,405.815,409.715,411.645,415.207,416.48199999999997,418.505,422.958,426.143,428.216,429.698,433.481,435.056,437.156,441.161,444.944,448.727,453.843,457.697,460.882,462.956,466.25600000000003,468.224,471.786,473.061,475.084,478.646,481.831,485.614,489.469,492.654,496.437,499.812,501.786,505.27,508.832,510.10699999999997,512.16,515.723,518.908,521.501,525.284,528.697,532.11" svgx:width="0.48,0.17,0.55,0.63,0.45,0.53,0.54,0.45,0.55,0.49,0.21,0.36,0.53,0.53,0.29,0.48,0.55,0.5,0.17,0.55,0.5,0.29,0.45,0.36,0.45,0.53,0.53,0.45,0.55,0.5,0.45,0.21,0.52,0.55,0.5,0.17,0.55,0.63,0.45,0.29,0.21,0.53,0.21,0.55,0.56,0.53,0.53,0.72,0.54,0.45,0.29,0.44,0.55,0.5,0.17,0.55,0.5,0.45,0.53,0.54,0.45,0.53,0.45,0.55,0.49,0.5,0.17,0.55,0.5,0.45,0.36,0.53,0.48,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">6. Nanda Kishore R, Prasanna Raju Y, Harini Chowdary V, Vandana KR, Rasheed</text>
   <text y="677.309" x="319.748,323.902,325.17699999999996,327.231,330.494,334.199,336.793,340.576,346.362,349.737,351.665,357.152,358.42699999999996,360.509,363.773,367.556,369.038,370.52,374.57,376.496,379.09,382.503,383.985,385.935,388.004,393.79,395.272,398.385,400.459,404.242,407.655,413.44,417.145,418.627,421.221,422.703,424.555,426.037,429.151,432.336,434.487,435.969,439.753,443.728,445.66,449.443,451.393,453.484,456.669,458.82,462.604,464.677,467.862,471.047,473.64,475.792,478.977,481.128,482.61,486.58500000000004,488.519,492.224,494.818,496.3,500.083,504.13300000000004,506.093,509.877,512.99,516.845,518.918,522.702,526.556,530.339,531.821,533.303,534.785" svgx:width="0.58,0.17,0.55,0.46,0.52,0.36,0.53,0.81,0.45,0.55,0.77,0.17,0.55,0.46,0.53,0.21,0.21,0.54,0.55,0.36,0.48,0.21,0.26,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.21,0.44,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.45,0.3,0.53,0.29,0.45,0.45,0.36,0.3,0.45,0.3,0.21,0.53,0.55,0.52,0.36,0.21,0.53,0.54,0.55,0.53,0.44,0.54,0.29,0.53,0.54,0.53,0.21,0.21,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">A, Sushma M. Solid self microemulsification of atorvastatin using hydrophilic</text>
   <text y="686.323" x="319.748,322.861,326.046,328.12,330.193,331.675,335.088,337.161,339.755,341.03,343.105,346.48,348.434,352.289,355.702,358.295,359.777,363.632,367.415,368.69,370.714,375.309,377.383,381.088,385.13800000000003,387.097,391.693,395.106,398.481,400.42,401.902,405.686,409.736,411.702,415.264,419.048,422.232,424.306,430.091,431.366,433.415,436.828,440.241,443.654,447.066,448.249,451.662,455.075,456.258,459.67,463.083,466.496" svgx:width="0.44,0.45,0.29,0.29,0.21,0.48,0.29,0.36,0.17,0.55,0.45,0.55,0.54,0.48,0.36,0.21,0.54,0.53,0.17,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.45,0.55,0.21,0.53,0.54,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">carriers: a design. Drug Dev Ind Pharm. 2015;41:1213</text>
   <text y="686.323" x="469.928" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="686.323" x="473.5,476.912,480.325" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">22.</text>
   <text y="695.337" x="304.724,308.137,309.412,319.748,323.31,327.094,329.167,331.319,334.732,336.90700000000004,338.91,342.914,345.358,349.811,351.08599999999996,353.139,357.144,360.927,364.112,366.185,371.971,375.155,379.13,381.088,386.874,391.398,392.673,394.751,396.233,400.016,402.168,405.581,408.174,410.326,411.808,415.591,418.776,420.351,422.416,423.898,427.012,432.797,436.652,440.435,443.62,445.772,447.254,450.55400000000003,452.52,456.374,458.448,462.153,466.20300000000003,468.167,470.319,472.392,475.577,479.36,481.954,485.808,489.591,491.665,493.817,495.092,497.136,500.321,504.29600000000005,506.264,509.969,513.823,517.678,520.863,523.014,526.427" svgx:width="0.48,0.17,0.55,0.5,0.53,0.29,0.3,0.48,0.29,0.55,0.56,0.34,0.63,0.17,0.55,0.56,0.53,0.45,0.29,0.81,0.45,0.53,0.55,0.81,0.63,0.17,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.21,0.44,0.81,0.54,0.53,0.45,0.3,0.21,0.44,0.55,0.54,0.29,0.52,0.54,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.17,0.55,0.45,0.53,0.55,0.52,0.54,0.54,0.45,0.3,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">7. Porter CJH, Charman WN. Intestinal lymphatic drug transport: an update.</text>
   <text y="704.351" x="319.748,323.902,327.756,331.131,333.071,337.666,339.74,343.445,347.495,349.454,354.05,357.463,358.945,360.427,363.802,365.725,369.287,372.7,375.885,377.15999999999997,379.217,382.63,386.043,389.456,392.869,394.051,397.464,400.877,402.06,405.473" svgx:width="0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.55,0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Adv Drug Deliv Rev. 2001;50:61</text>
   <text y="704.351" x="408.926" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="704.351" x="412.498,415.911,419.323" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">80.</text>
   <text y="713.309" x="304.724,308.137,309.412,319.748,323.31,326.495,330.279,336.064,339.249,343.22400000000005,345.146,350.632,354.786,356.061,358.128,362.581,365.766,367.84,372.955,376.14,379.923,382.517,386.492,388.458,392.021,393.296,395.318,400.804,402.286,404.36,407.174,410.549,412.553,418.039,422.193,423.46799999999996,425.479,429.932,433.637,436.23,438.824,442.008,443.49,447.46500000000003,449.46,452.723,453.998,456.036,460.489,464.194,466.787,469.381,472.566,474.048,478.023,480.017,484.171,485.44599999999997,487.444,492.189,494.262,497.447,499.022,501.107,502.589,504.071,507.925,509.407,513.457,515.393,519.247,522.432,525.026,528.438" svgx:width="0.48,0.17,0.55,0.5,0.45,0.53,0.81,0.45,0.53,0.55,0.77,0.58,0.17,0.55,0.63,0.45,0.29,0.72,0.45,0.53,0.36,0.53,0.55,0.5,0.17,0.55,0.77,0.21,0.29,0.4,0.45,0.55,0.77,0.58,0.17,0.55,0.63,0.52,0.36,0.36,0.45,0.21,0.53,0.55,0.46,0.17,0.55,0.63,0.52,0.36,0.36,0.45,0.21,0.53,0.55,0.58,0.17,0.55,0.67,0.29,0.45,0.21,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.45,0.36,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">8. Rahman MA, Harwansh R, Mirza MA, Hussain S, Hussain A. Oral lipid based</text>
   <text y="722.323" x="319.748,323.602,325.676,329.381,333.431,335.338,339.192,342.605,344.087,345.569,348.754,352.167,354.24,357.54,359.545,362.139,365.253,367.846,369.998,373.411,379.486,381.315,383.167,384.649,388.504,392.359,396.213,398.807,400.659,401.93399999999997,403.991,405.844,409.627,411.701,417.486,421.191,422.673,425.858,428.01,429.491,433.275,437.058,438.33299999999997,440.444,443.557,447.341,450.526,452.599,455.784,458.897,461.049,464.462,466.535,468.017,470.832,474.016,476.168,477.65,481.434,485.40900000000005,487.385,490.57,494.353,498.403,500.367,503.552,507.407,511.261,512.743,514.225,517.339,520.524,522.675,524.157,527.941,531.724,532.999,535.063" svgx:width="0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.55,0.26,0.21,0.54,0.54,0.54,0.36,0.26,0.17,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.44,0.53,0.45,0.29,0.45,0.44,0.3,0.48,0.29,0.21,0.4,0.45,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.45,0.54,0.54,0.21,0.21,0.44,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">drug delivery system (lbdds): formulation, characterization and application: a</text>
   <text y="731.337" x="319.748,321.821,325.234,328.419,329.901,333.314,338.429,339.70399999999995,341.744,345.748,349.453,351.526,353.701,355.746,360.342,362.415,366.12,370.17,372.13,376.726,380.139,381.62,383.102,386.287,387.56199999999995,389.648,393.061,396.474,399.887,403.299,404.482,407.895,409.078,412.491,415.903" svgx:width="0.29,0.48,0.45,0.21,0.48,0.72,0.17,0.55,0.56,0.52,0.29,0.29,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">review. Curr Drug Deliv. 2011;8:330</text>
   <text y="731.337" x="419.301" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="731.337" x="422.872,426.285,429.698" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">45.</text>
   <text y="39.005" x="56.693,61.021,64.853,67.429,71.261,77.925,80.501,84.501,88.996,93.492" svgx:width="0.54,0.48,0.32,0.48,0.83,0.32,0.5,0.56,0.56,0.47" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:8.0px;stroke:none;">Katamreddy</text>
   <text y="39.005" x="99.552,103.128,105.608,107.999,112.159,113.903,115.58300000000001,117.978,121.474,123.218,127.378,129.122,133.282,136.162,138.557,140.301,144.541,146.948,151.948,155.524,159.684,161.428,163.924,168.16400000000002,170.532,174.692,178.94,183.1,185.499,190.659,192.403,195.315,198.891,203.051,205.963" svgx:width="0.45,0.31,0.55,0.52,0.22,0.21,0.55,0.44,0.22,0.52,0.22,0.52,0.36,0.55,0.22,0.53,0.55,0.63,0.45,0.52,0.22,0.31,0.53,0.55,0.52,0.53,0.52,0.55,0.64,0.22,0.36,0.45,0.52,0.36,0.45" style="fill:rgb(19,20,19);font-family:BgxxryAdvTT7329fd89.I;font-size:8.0px;stroke:none;">et al. Lipids in Health and Disease</text>
   <text y="39.005" x="211.861,213.557,215.829,219.932,224.036,228.14,232.244,234.516,236.212,240.316,244.42,246.076,250.18,254.284,258.388" svgx:width="0.21,0.28,0.51,0.51,0.51,0.51,0.28,0.21,0.51,0.51,0.21,0.51,0.51,0.51,0.21" style="fill:rgb(19,20,19);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;"> (2018) 17:112 </text>
   <text y="39.005" x="500.143,504.391,508.222,512.638,516.638,519.022,523.1020000000001,525.485,529.813,532.133,534.499" svgx:width="0.53,0.48,0.55,0.5,0.55,0.51,0.55,0.54,0.29,0.55,0.51" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:8.0px;stroke:none;">Page 6 of 8</text>
  </g>
 </g>
</svg>
